Processing 00000000.tx.1: Apolipoprotein E4 Stimulates cAMP Response Element-binding Protein Transcriptional Activity through the Extracellular Signal-regulated Kinase Pathway* Nobutaka Ohkubo, Noriaki Mitsuda, Michio Tamatani, Atsushi Yamaguchi, Young-Don Lee, Toshio Ogihara**, Michael P. 

Phrase: "Apolipoprotein E4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Stimulates"

Phrase: "cAMP Response Element-binding Protein Transcriptional Activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   845   C2266866:Binding Activity [Molecular Function]
   829   C1537044:protein activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C3158668:cAMP response element binding [Genetic Function]

Phrase: "through the Extracellular Signal-regulated Kinase Pathway"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0037080:Signal Pathway [Molecular Function]
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]
   750   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   750   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "* Nobutaka Ohkubo,"

Phrase: "Noriaki Mitsuda,"

Phrase: "Michio Tamatani,"

Phrase: "Atsushi Yamaguchi,"

Phrase: "Young-Don Lee,"

Phrase: "Toshio Ogihara"

Phrase: "*"

Phrase: "*,"

Phrase: "Michael P."
Processing 00000000.tx.2: Vitek, and Masaya Tohyama From the Department of Anatomy and Neuroscience, and the **Department of Geriatric Medicine, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871,Japan, the CREST, Japan Science and Technology, Japan, the Department of Anatomy, Ajou University School of Medicine, Suwon 442-749,Korea, and the Division of Neurology, Duke University Medical Center, Durham, North Carolina 27710 Received for publication, June 12,2000, and in revised form, September 26,2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Inheritance of the 4 allele of the apolipoprotein E gene (APOE4) is a major risk factor for the development of Alzheimer's disease (AD). 

Phrase: "Vitek,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553145:Vitek [Laboratory Procedure]

Phrase: "and"

Phrase: "Masaya Tohyama From the Department of Anatomy"

Phrase: "and"

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "and"

Phrase: "the **Department of Geriatric Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0587471:Geriatric medicine department [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "Graduate School of Medicine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0870614:graduate school [Manufactured Object,Organization]
   770   C0036375:School [Manufactured Object,Organization]
   770   C0588053:Graduate [Population Group]
   770   C1547183:Graduate [Idea or Concept]

Phrase: "Osaka University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Suita,"

Phrase: "Osaka 565-0871,"

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "the CREST,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0332243:crest [Functional Concept]
  1000   C1947915:Crest [Spatial Concept]
  1000   C2948667:Crest [Pharmacologic Substance]
   907 E C0229465:cristae [Body Part, Organ, or Organ Component]
   907 E C0230844:cristae [Cell Component]

Phrase: "Japan Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Technology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039421:Technology [Occupation or Discipline]

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "the Department of Anatomy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Ajou University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "Suwon 442-749,"

Phrase: "Korea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022771:Korea [Geographic Area]
   928 E C1556095:Korean [Population Group]

Phrase: "and"

Phrase: "the Division of Neurology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C0228059:division nervous system [Body System]
   770   C1293097:Division [Therapeutic or Preventive Procedure]
   770   C2919030:Division [Organization]
   770   C2919031:Division [Activity]

Phrase: "Duke University Medical Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0041740:University [Manufactured Object,Organization]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]
   812   C1446468:Duke [Laboratory Procedure]

Phrase: "Durham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454851:Durham [Geographic Area]

Phrase: "North Carolina 27710"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0028407:North Carolina [Geographic Area]
   827   C1709269:North [Spatial Concept]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "June 12,"

Phrase: "2000,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "September 26,"

Phrase: "2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Inheritance of the 4 allele of the apolipoprotein E gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0242538:Inheritance [Quantitative Concept]
   739   C0728826:Inheritance [Functional Concept]

Phrase: "(APOE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: ")"

Phrase: "is"

Phrase: "a major risk factor for the development of Alzheimer's disease"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   795   C0850664:risk factor (of) disease [Finding]
           disease risk factor
   760   C0035648:Risk factor [Quantitative Concept]
   757   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   757   C0679238:disease factor [Functional Concept]
   757   C0960756:factor A [Organic Chemical]
   757   C1281905:disease risk [Finding]
   739   C0035647:Risk [Qualitative Concept]
   739   C1521761:Factor [Functional Concept]
   739   C2827422:Factor [Conceptual Entity]

Phrase: "(AD"

Phrase: ")."
Processing 00000000.tx.3: Although the association between APOE4 and AD is well documented, the mechanism by which apolipoprotein E exerts an isoform-specific effect on neurons in disease is unknown. 

Phrase: "Although"

Phrase: "the association between APOE4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "AD"

Phrase: "is"

Phrase: "well documented,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0205170:Well [Qualitative Concept]
   861   C1301725:Documented [Health Care Activity]
   861   C1609436:documented [Idea or Concept]
   861   C3146287:Well [Manufactured Object]
   827 E C1301746:document [Intellectual Product]
   827 E C1547673:Document [Intellectual Product]

Phrase: "the mechanism by which apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "an isoform-specific effect on neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.4: In this report, we demonstrate that apoE4 stimulates the transcriptional activity of cAMP-response element-binding protein (CREB) by activating the extracellular signal-regulated kinase (ERK) cascade in rat primary hippocampal neurons. 

Phrase: "In this report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "stimulates"

Phrase: "the transcriptional activity of cAMP-response element-binding protein (CREB)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C1537044:protein activity [Molecular Function]
   762   C2266866:Binding Activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "by activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "the extracellular signal-regulated kinase (ERK) cascade in rat primary hippocampal neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.5: In contrast, apoE3 was unable to stimulate CREB transcriptional activity and unable to activate the ERK pathway. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "stimulate"

Phrase: "CREB transcriptional activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   845   C2266866:Binding Activity [Molecular Function]
   829   C1537044:protein activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C3158668:cAMP response element binding [Genetic Function]

Phrase: "and"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the ERK pathway."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0037080:Signal Pathway [Molecular Function]
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]
   750   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   750   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.6: Elevation of intracellular Ca2+ levels are also involved because treatment with receptor-associated protein, nifedipine, MK801, removal of Ca2+ from the medium and dantrolene all served to inhibit calcium elevation and attenuate the activation of CREB. 

Phrase: "Elevation of intracellular Ca2+ levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439775:Elevation [Therapeutic or Preventive Procedure]
   760   C0702240:Elevation [Spatial Concept]

Phrase: "are"

Phrase: "also"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "because"

Phrase: "treatment with receptor-associated protein,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "nifedipine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028066:Nifedipine [Organic Chemical,Pharmacologic Substance]

Phrase: "MK801,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]

Phrase: "removal of Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015252:Removal [Therapeutic or Preventive Procedure]
   790   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "from the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "dantrolene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010976:Dantrolene [Organic Chemical,Pharmacologic Substance]

Phrase: "all"

Phrase: "served"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "calcium elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439775:Elevation [Therapeutic or Preventive Procedure]
   861   C0702240:Elevation [Spatial Concept]

Phrase: "and"

Phrase: "attenuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "the activation of CREB."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   815   C2245434:activation of protein binding [Molecular Function]
   793   C2259194:activation of binding [Molecular Function]
   767   C0599177:protein activation [Genetic Function]
   744   C1879547:Activation [Activity]
   703   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.7: Treatment with an apoE peptide was also found to facilitate transcription of the CREB-dependent genes, c-fos and Bcl-2. 

Phrase: "Treatment with an apoE peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "was"

Phrase: "also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "transcription of the CREB-dependent genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0040649:genes transcription [Genetic Function]
           Transcription

Phrase: "c-fos"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085301:c fos [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0085940:c fos [Gene or Genome]
  1000   C0087140:c-fos [Gene or Genome]

Phrase: "and"

Phrase: "Bcl-2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]
Processing 00000000.tx.8: In contrast to treatment with apoE3, our findings suggest apoE4 and apoE-peptide induce a novel signaling pathway.  

Phrase: "In contrast to treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with apoE3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "and"

Phrase: "apoE-peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a novel signaling pathway."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0037083:signaling pathway [Cell Function]
   901   C0086982:Signaling Pathway [Molecular Function]
   884 E C0037080:Signal Pathway [Molecular Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.9: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Alzheimer's disease is a devastating neurological disorder characterized by progressive memory loss and cognitive deficits. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "a devastating neurological disorder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027765:Neurological disorder [Disease or Syndrome]
   827   C0012634:Disorder [Disease or Syndrome]

Phrase: "characterized by progressive memory loss"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0002622:Memory loss [Mental or Behavioral Dysfunction]
   806   C0751295:Memory Loss [Sign or Symptom]
   760   C0025260:Memory [Mental Process]
   760   C0205329:Progressive [Functional Concept]
   760   C0700327:memory [Finding]
   760   C1517945:Loss [Quantitative Concept]
   760   C1706377:Memory [Manufactured Object]
   760   C1880022:Characterized [Activity]
   704 E C0679055:mnemonic [Mental Process]

Phrase: "and"

Phrase: "cognitive deficits."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]
Processing 00000000.tx.10: To date, four genes have been reported to be associated with Alzheimer's disease phenotypes including the amyloid precursor protein gene on chromosome 21(1-4), the presenilin-1 gene on chromosome 14(5), the presenilin-2 gene on chromosome 1(6-7), and the apolipoprotein-E (APOE) 1gene on chromosome 19(8-10). 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "four genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with Alzheimer's disease phenotypes"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0243083:associated disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0031437:Phenotypes [Organism Attribute]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1285572:Phenotype [Laboratory Procedure]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the amyloid precursor protein gene on chromosome 21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C1883412:Gene 21 protein [Amino Acid, Peptide, or Protein]
   770   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0017337:Gene [Gene or Genome]

Phrase: "(1-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "the presenilin-1 gene on chromosome 14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   814   C1418985:Presenilin 1 Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the presenilin-2 gene on chromosome 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C1418985:Presenilin 1 Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]

Phrase: "(6-7"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the apolipoprotein-E (APOE) 1gene on chromosome 19"

Phrase: "(8-10"

Phrase: ")."
Processing 00000000.tx.11: There are three common alleles of the APOE gene: 3 is the most common representing ~78% of all APOE alleles, 4 representing 15% and 2 representing 7% (11). 

Phrase: "There"

Phrase: "are"

Phrase: "three common alleles of the APOE gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0002085:Alleles [Gene or Genome]

Phrase: ":"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "is"

Phrase: "the most common representing ~78% of all APOE alleles,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0002085:Alleles [Gene or Genome]
   739   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205214:Common [Quantitative Concept]
   739   C1522138:Common [Functional Concept]
   739   C3245511:common [Intellectual Product]
   706   C1882932:Represent [Activity]

Phrase: "4"

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "15%"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "7%"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.12: Although these alleles give six possible genotypes, the risk of Alzheimer's disease is increased, and the age of onset distribution is earlier, with each dose of 4 (8). 

Phrase: "Although"

Phrase: "these alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "six possible genotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotypes [Organism Attribute]

Phrase: "the risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "and"

Phrase: "the age of onset distribution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   797   C0001782:Age Distribution [Quantitative Concept]
   760   C0001779:Age [Organism Attribute]

Phrase: "is"

Phrase: "earlier,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "with each dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178602:Dose [Quantitative Concept]
  1000   C0869039:Dose [Quantitative Concept]
  1000   C1114758:Dose # [Clinical Attribute]

Phrase: "of 4"

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.13: While the influence of the APOE-4 genotype was clearly demonstrated, the biological mechanism mediated by apoE4, the translated protein isoform derived from the 4 allele of APOE gene remains speculative. 

Phrase: "While"

Phrase: "the influence of the APOE-4 genotype"

Phrase: "was"

Phrase: "clearly"

Phrase: "demonstrated"

Phrase: ","

Phrase: "the biological mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "mediated by apoE4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C2984964:APOE4 [Laboratory Procedure]

Phrase: "the translated protein isoform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0597298:protein isoform [Amino Acid, Peptide, or Protein]
           Isoform

Phrase: "derived from the 4 allele of APOE gene"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   807   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   790   C1412481:Apolipoprotein E gene [Gene or Genome]
   784   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   764   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1445865:Apolipoprotein gene [Gene or Genome]
   742   C0002085:Allele [Gene or Genome]
           allelic gene
   742   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0017337:Gene [Gene or Genome]
   742   C1441547:Derived [Qualitative Concept]
   742   C3245521:derived [Idea or Concept]

Phrase: "remains"

Phrase: "speculative."
Processing 00000000.tx.14: Several hypotheses have been proposed regarding potential mechanisms where apoE4 enhances the risk for Alzheimer's disease. 

Phrase: "Several hypotheses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "regarding"

Phrase: "potential mechanisms where apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   812   C2984964:APOE4 [Laboratory Procedure]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the risk for Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.15: One interesting hypothesis is that apoE4 itself causes toxicity to hippocampal neurons, but that apoE3 does not (12-13). 

Phrase: "One interesting hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "that apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "itself"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "toxicity to hippocampal neurons,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "but"

Phrase: "that apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "does"

Phrase: "not (12-13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]

Phrase: ")."
Processing 00000000.tx.16: A 22-kDa thrombin cleavage fragment of apoE4 known as "truncated apoE4" and an apoE peptide consisting of a tandem repeat of amino acid residues 141-149 of apoE showed higher toxicity to neurons than apoE4 itself (14-15). 

Phrase: "A 22-kDa thrombin cleavage fragment of apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "as ""truncated apoE4"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   827   C2984964:APOE4 [Laboratory Procedure]

Phrase: "and"

Phrase: "an apoE peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "consisting of a tandem repeat of amino acid residues 141-149 of apoE"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   750   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   750   C0039290:Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   750   C2917660:Amino Acid [Pharmacologic Substance]
   735   C0001128:Acid [Chemical]
   735   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   735   C0202406:Acid [Laboratory Procedure]
   735   C0205341:Repeat [Functional Concept]
   735   C0523511:APOE [Laboratory Procedure]
   735   C1412481:APOE [Gene or Genome]
   735   C1547730:Repeat [Temporal Concept]
   735   C1705914:Repeat [Conceptual Entity]
   702   C0332529:CONSIST [Qualitative Concept]
   702   C1709915:Residue [Conceptual Entity]
   702   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "higher toxicity to neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "than apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "itself"

Phrase: "(14-15"

Phrase: ")."
Processing 00000000.tx.17: Their toxicity was apoE receptor-mediated (14) and involved calcium influx (16). 

Phrase: "Their toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "was"

Phrase: "apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "receptor-mediated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086597:mediated [Social Behavior]
   861   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(14"

Phrase: ")"

Phrase: "and"

Phrase: "involved calcium influx"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.18: Based on these reports, we started to study the mechanism of apoE toxicity using the synthetic apoE peptide. 

Phrase: "Based on these reports,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0684224:Reports [Intellectual Product]
   770   C0700287:reports [Health Care Activity]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
   737 E C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "started"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1272689:Started [Qualitative Concept]
   966 E C0439659:Start [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the mechanism of apoE toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the synthetic apoE peptide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.19: We employed the Mercury Pathway Profiling System (CLONTECH) to elucidate the mechanistic pathways activated in the presence of apoE peptide. 

Phrase: "We"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "the Mercury Pathway Profiling System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(CLONTECH"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "the mechanistic pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "activated in the presence of apoE peptide."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1412481:APOE [Gene or Genome]
   748   C1879547:Activated [Activity]
   714 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.20: This system evaluates several cis-acting enhancer elements such as AP1, CRE, HSE, Myc, NFB, and serum response element and among them, transcription from the CRE element was found to be activated. 

Phrase: "This system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "evaluates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "several cis-acting enhancer elements such as AP1,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   782   C0599780:cis acting element [Nucleotide Sequence]
   770   C0014290:Enhancer Elements [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0013879:Elements [Element, Ion, or Isotope]
   711 E C1705248:Element [Conceptual Entity]

Phrase: "CRE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511573:CRE [Gene or Genome]

Phrase: "HSE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1537381:HSE [Gene or Genome]
  1000   C3540642:HSE [Gene or Genome]

Phrase: "Myc,"

Phrase: "NFB,"

Phrase: "and"

Phrase: "serum response element"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0969709:Serum Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0229671:Serum [Body Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "and among them,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "transcription from the CRE element"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040649:Transcription [Genetic Function]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "activated."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.21: In addition to the apoE peptide, a specific isoform of the apoE protein was found to stimulate the phosphorylation that activates CREB. 

Phrase: "In addition to the apoE peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "a specific isoform of the apoE protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0597298:protein isoform [Amino Acid, Peptide, or Protein]
           Isoform

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "the phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "that"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "CREB."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]
Processing 00000000.tx.22: We then examined the pathway upstream of CREB activation and found that ERK and the apoE receptor are involved in this same pathway. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the pathway upstream of CREB activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   777   C1514528:Protein Activation Pathway [Functional Concept]
   777   C3156336:protein activation pathway [Molecular Function]
   739   C1704259:Pathway [Molecular Function]
   739   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that ERK"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   979   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   979   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0521119:Extracellular [Cell Component]
   812   C0851285:Regulated [Governmental or Regulatory Activity]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "the apoE receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051300:ApoE Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "involved in this same pathway."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0445247:Same [Qualitative Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.23: Downstream of CREB, the expression of c-fos and Bcl-2 genes that are modulated by activated CREB, were also increased. 

Phrase: "Downstream of CREB,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "the expression of c-fos"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Bcl-2 genes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0376515:Genes, bcl-2 [Gene or Genome]
           Bcl-2
   988 E C1704467:BCL-2 Gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "are"

Phrase: "modulated by activated CREB,"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   869   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C3158668:cAMP response element binding [Genetic Function]
   800   C1511573:cAMP Response Element [Gene or Genome]
   770   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   767 E C0033618:Protein Binding [Molecular Function]
   767   C1148918:cAMP binding [Molecular Function]
   744   C0013879:Element [Element, Ion, or Isotope]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   744   C0243122:binding [Functional Concept]
   744   C0443264:Modulated [Spatial Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1704632:Response [Finding]
   744   C1705248:Element [Conceptual Entity]
   744   C1706817:Response [Intellectual Product]
   744   C1879547:Activated [Activity]
   744   C2911692:Response [Mental Process]
   711 E C1515877:Activate [Functional Concept]

Phrase: "were"

Phrase: "also"

Phrase: "increased."
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.24: Our finding that apoE4 stimulates phosphorylation of CREB through an ERK pathway to increase transcription of specific genes while apoE3 does not, suggests a mechanism of apoE isoform-specific function on neurons.  

Phrase: "Our"

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "stimulates"

Phrase: "phosphorylation of CREB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   748   C0031715:Phosphorylation [Molecular Function]
   731   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "through an ERK pathway to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0037080:Signal Pathway [Molecular Function]
   799   C1704259:Pathway [Molecular Function]
   799   C1705987:Pathway [Conceptual Entity]
   713   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   713   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "transcription of specific genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0040649:genes transcription [Genetic Function]
           Transcription

Phrase: "while"

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "does"

Phrase: "not,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a mechanism of apoE isoform-specific function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "on neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.25: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Reagents-- Recombinant apolipoprotein E3 and apolipoprotein E4 were purchased from Calbiochem (San Diego, CA); 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "--"

Phrase: "Recombinant apolipoprotein E3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0052199:Apolipoprotein E-3 [Amino Acid, Peptide, or Protein]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1537525:E3 [Gene or Genome]

Phrase: "and"

Phrase: "apolipoprotein E4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "purchased from Calbiochem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: ";"
Processing 00000000.tx.26: U0126 and cAMP-dependent protein kinase-specific inhibitor from Promega (Madison, WI); 

Phrase: "U0126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "cAMP-dependent protein kinase-specific inhibitor from Promega"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   767   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   767   C3537023:kinase inhibitor [Molecular Function]
   767   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.27: nifedipine and dantrolene from Sigma; 

Phrase: "nifedipine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028066:Nifedipine [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "dantrolene from Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0010976:Dantrolene [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.28: (+)-MK801 hydrogen malate and KN62 from Research Biochemicals International (Natick, MA); 

Phrase: "(+"

Phrase: ")-"

Phrase: "MK801 hydrogen malate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0220873:malate [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "KN62 from Research Biochemicals"

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: "(Natick,"

Phrase: "MA"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.29: RAP and anti-apolipoprotein E antibody (IB5-E1) from Progen Biotechnik (Heidelberg, Germany); 

Phrase: "RAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416920:RAP [Gene or Genome]

Phrase: "and"

Phrase: "anti-apolipoprotein E antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   708   C0313106:Anti e [Amino Acid, Peptide, or Protein,Immunologic Factor]
   708   C0947659:Anti E [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(IB5-E1"

Phrase: ")"

Phrase: "from Progen Biotechnik"

Phrase: "(Heidelberg,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.30: anti-CREB antibody, anti-phospho-CREB antibody, anti-ERK antibody, and anti-phospho-ERK antibody from New England Biolabs (Beverly, MA); 

Phrase: "anti-CREB antibody,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   893   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C3158668:cAMP response element binding [Genetic Function]

Phrase: "anti-phospho-CREB antibody,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   892   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   723   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "anti-ERK antibody,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   895   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   713   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   713   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "anti-phospho-ERK antibody from New England Biolabs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   738   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Beverly,"

Phrase: "MA"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.31: anti-c-Fos antibody from Santa Cruz Biotechnology (Santa Cruz, CA); 

Phrase: "anti-c-Fos antibody from Santa Cruz Biotechnology"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0051967:anti-c antibody [Immunologic Factor]
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0368815:antibody c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Santa Cruz,"

Phrase: "CA)"

Phrase: ";"
Processing 00000000.tx.32: mouse anti-actin monoclonal antibody (C4) from Chemicon International (Temecula, CA) and anti-Bcl-2 antibody from MBL (Nagoya, Japan). 

Phrase: "mouse anti-actin monoclonal antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   911   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   888   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0746619:monoclonal [Finding]

Phrase: "(C4) from Chemicon"

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: "(Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555271:Temecula [Population Group]

Phrase: "CA)"

Phrase: "and"

Phrase: "anti-Bcl-2 antibody from MBL (Nagoya,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.33: ApoE Peptide Synthesis-- A 30-amino acid apoE peptide, which is a tandem repeat of apoE amino acid residues 141-155 (LRKLRKRLLRDADDL) was synthesized by the solid-phase method as described previously (17) and greater than 95% purity was determined by high performance liquid chromatography and mass spectrometry. 

Phrase: "ApoE Peptide Synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1327133:peptide synthesis [Molecular Function]
   901   C1518961:Peptide Synthesis [Research Activity]
   901   C2945683:Peptide synthesis [Molecular Function]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]

Phrase: "--"

Phrase: "A 30-amino acid apoE peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "is"

Phrase: "a tandem repeat of apoE amino acid residues 141-155"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0039290:Tandem Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]
   739   C0205341:Repeat [Functional Concept]
   739   C1547730:Repeat [Temporal Concept]
   739   C1705914:Repeat [Conceptual Entity]

Phrase: "(LRKLRKRLLRDADDL"

Phrase: ")"

Phrase: "was"

Phrase: "synthesized by the solid-phase method"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0025663:Method [Intellectual Product]
   753   C0205208:Solid [Qualitative Concept]
   753   C0205390:Phase [Temporal Concept]
   753   C0302909:Solid [Substance]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
   753   C1378566:Solid [Biomedical or Dental Material]
   753   C1883254:Synthesized [Activity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(17"

Phrase: ")"

Phrase: "and"

Phrase: "greater than 95% purity"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0439093:Greater Than [Quantitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "was"

Phrase: "determined by high performance liquid chromatography"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   882   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   882   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   882   C1579831:High performance liquid chromatography [Functional Concept]
   790   C0008565:Liquid Chromatography [Laboratory Procedure]
   753   C0008550:Chromatography [Laboratory Procedure]
   753   C0205250:High [Qualitative Concept]
   753   C0302908:Liquid [Substance]
   753   C0597198:Performance [Individual Behavior]
   753   C1299351:High [Qualitative Concept]
   753   C1304698:Liquid [Finding]
   753   C1546699:Liquid NOS [Intellectual Product]
   753   C1561501:Liquid NOS [Substance]
   753   C1882330:Performance [Activity]
   753   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "mass spectrometry."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.34: Cell Culture-- Primary cultures of rat hippocampal neurons were prepared from Wistar rats at embryonic day 18as described previously (18). 

Phrase: "Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "--"

Phrase: "Primary cultures of rat hippocampal neurons"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0010453:Cultures [Idea or Concept]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "prepared from Wistar rats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0034716:Rats, Wistar [Mammal]
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C2700262:Wistar [Mammal]
   737   C1521827:Prepare [Functional Concept]

Phrase: "at embryonic day 18as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.35: Cells were routinely propagated in Dulbecco's modified Eagle's medium (Sigma) with 10% fetal calf serum (Life Technologies, Inc.). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "routinely"

Phrase: "propagated in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "with 10% fetal calf serum"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.36: All experiments were performed on cells cultured for 5to 8days. 

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed on cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0884358:Performed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "cultured for 5to 8days."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.37: Primary astrocyte cultures were prepared from neonatal apoE-deficient mice as described previously (19) with minor modifications. 

Phrase: "Primary astrocyte cultures"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0004112:Astrocyte [Cell]
   827   C0010453:Cultures [Idea or Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "prepared from neonatal apoE-deficient mice"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011155:Deficient [Functional Concept]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]
   753   C1552240:Neonatal [Professional or Occupational Group]
   753   C1552264:Neonatal [Professional or Occupational Group]
   753   C1636779:% deficient [Quantitative Concept]
   753   C2939425:Neonatal [Temporal Concept]
   719   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(19"

Phrase: ")"

Phrase: "with minor modifications."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.38: In brief, apoE-deficient mice were purchased from Taconic Farms (Germantown, NY) and backbred to C57BL/6 for at least six generations, brains were removed from neonatal apoE-deficient mice within 24h of birth, meninges were removed, and brain tissues were digested at 37C with Dispase II (Rochem Molecular Biochemicals, Germany) in PBS. 

Phrase: "In brief, apoE-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "purchased from Taconic Farms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557759:farms [Geographic Area]
   770   C0869011:purchased [Activity]

Phrase: "(Germantown,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "backbred to C57BL/6"

Phrase: "for"

Phrase: "at least six generations,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0079411:Generations [Temporal Concept]
   793 E C3146294:Generation [Activity]
   727 E C1414672:Genesis [Gene or Genome]
   727 E C2984892:Genesis [Gene or Genome]

Phrase: "brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "removed from neonatal apoE-deficient mice"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011155:Deficient [Functional Concept]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0523511:APOE [Laboratory Procedure]
   753   C0849355:Removed [Qualitative Concept]
   753   C1412481:APOE [Gene or Genome]
   753   C1552240:Neonatal [Professional or Occupational Group]
   753   C1552264:Neonatal [Professional or Occupational Group]
   753   C1636779:% deficient [Quantitative Concept]
   753   C2939425:Neonatal [Temporal Concept]
   719 E C1883720:Remove [Activity]
   719 E C3244314:remove [Functional Concept]

Phrase: "within 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "of birth,"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
  1000   C0005615:Birth [Organism Function]
  1000   C1550722:birth [Idea or Concept]
  1000   C3245487:birth [Intellectual Product]
   944 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   944 E C0314603:Genetic [Functional Concept]
   944 E C0454729:Natal [Geographic Area]
   916 E C0035150:Reproduction [Organism Function]
   916 E C0079946:origin [Classification]
   916 E C0439659:Origin [Temporal Concept]
   916 E C1550512:origin [Intellectual Product]
   900 E C0559522:Genital [Body System]
   900 E C1546649:Genital [Intellectual Product]
   900 E C1550642:Genital [Body Substance]
   893 E C0205313:Original [Idea or Concept]
   893 E C2347409:Original [Occupational Activity]
   880 E C0598240:originality [Mental Process]

Phrase: "meninges"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025285:Meninges [Body Part, Organ, or Organ Component]
  1000   C2332324:Meninges [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "brain tissues"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0440746:brain tissues [Tissue]
   966 E C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0040300:Tissues [Tissue]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "digested at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "with Dispase II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0114365:dispase II [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Rochem Molecular Biochemicals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "in PBS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]
Processing 00000000.tx.39: The mixture was centrifuged (3000g for 10min), plated in 175-cm2 culture flasks (two brains/flask), and cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. 

Phrase: "The mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "(3000g for 10min"

Phrase: ")"

Phrase: ","

Phrase: "plated in 175-cm2 culture flasks"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0180454:Culture plate [Medical Device]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0439479:cm2 [Quantitative Concept]
   753   C0555206:CM2 [Congenital Abnormality]
   753   C0872171:flasks [Medical Device]
   753   C2242979:Culture [Laboratory Procedure]
   719   C0005971:Plate [Medical Device]
   719   C1139930:plate [Medical Device]
   719   C3537155:Plate [Manufactured Object]

Phrase: "(two brains/flask"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0872171:Flask [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 10% fetal calf serum."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.40: After 10days, cells were incubated for 48h with cytosine arabinofuranoside (10g/ml; Wako, Osaka, Japan) to prevent fibroblast overgrowth. 

Phrase: "After 10days,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 48h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442464:48H [Temporal Concept]

Phrase: "with cytosine arabinofuranoside"

Phrase: "(10g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "; Wako,"

Phrase: "Osaka,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "fibroblast overgrowth."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1849265:Overgrowth [Finding]
Processing 00000000.tx.41: Astrocytes were then separated from microglia and oligodendroglia by agitation on a shaking platform (Bioshaker BR-30L, Tautek, Tokyo, Japan) and identified by immunoreactivity with an anti-GFAP antibody. 

Phrase: "Astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "separated from microglia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0086972:Separated [Finding]
   790   C0206116:Microglia [Cell]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]
   718 E C0521398:Microglial [Body Location or Region]

Phrase: "and"

Phrase: "oligodendroglia by agitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0028944:Oligodendroglia [Cell]

Phrase: "on a shaking platform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710360:Platform [Research Device]

Phrase: "(Bioshaker BR-30L,"

Phrase: "Tautek,"

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "identified by immunoreactivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205396:Identified [Qualitative Concept]
   790   C0597879:immunoreactivity [Molecular Function]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "with an anti-GFAP antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.42: Cultures used for experiments were >98% astrocytes based on these techniques. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "used for experiments"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0681814:Experiments [Research Activity]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1706386:Experiment [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: ">98% astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "based on these techniques."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0025664:techniques [Intellectual Product]
   770   C0449851:Techniques [Functional Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.43: Stimulation of Primary Astrocytes and Quantification of TNF-- Inhibition of secretion of TNF from primary astrocytes by apoE was quantified as described previously (20). 

Phrase: "Stimulation of Primary Astrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "Quantification of TNF-- Inhibition of secretion of TNF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1709793:Quantification [Quantitative Concept]

Phrase: "from primary astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "by apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "was"

Phrase: "quantified"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.44: Briefly, primary astrocytes from apoE-deficient mice were plated on 96-well tissue culture dishes at a density of 20,000cells/well and incubated in serum-free media (Opti-MEM I, Life Technologies, Inc.) containing 1% N2 supplement (Life Technologies, Inc.). 

Phrase: "Briefly,"

Phrase: "primary astrocytes from apoE-deficient mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0004112:Astrocytes [Cell]
   750   C1522173:Mouse Astrocyte [Cell]

Phrase: "were"

Phrase: "plated on 96-well tissue culture dishes"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   797   C0492792:DISH, TISSUE CULTURE [Medical Device]
   778   C0040284:Tissue culture [Laboratory Procedure]
   757   C0180454:Culture plate [Medical Device]
   748   C0010453:Culture [Idea or Concept]
   748   C0040300:Tissue [Tissue]
   748   C0205170:Well [Qualitative Concept]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C1547928:Tissue [Intellectual Product]
   748   C2242979:Culture [Laboratory Procedure]
   748   C3146287:Well [Manufactured Object]
   714   C0005971:Plate [Medical Device]
   714   C0020498:DISH [Disease or Syndrome]
   714   C1139930:plate [Medical Device]
   714   C3537155:Plate [Manufactured Object]

Phrase: "at a density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "of 20,"

Phrase: "000cells/well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "incubated in serum-free media"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   862   C0085414:Serum-Free Media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C0229671:Serum [Body Substance]
   760   C0332296:free [Functional Concept]
   760   C1254021:Media [Tissue]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "(Opti-MEM I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.)"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% N2 supplement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0242295:Supplement [Food]
   827   C1947943:Supplement [Intellectual Product]
   827   C2348609:Supplement [Functional Concept]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.45: The following day, recombinant apoE3, apoE4, or control protein (denatured apoE3 by boiling for 30min) was added. 

Phrase: "The following day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "recombinant apoE3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "apoE4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "or"

Phrase: "control protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(denatured apoE3 by boiling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "for 30min"

Phrase: ")"

Phrase: "was"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.46: 24h later, 100ng/ml lipopolysaccharide (Sigma) was added. 

Phrase: "24h later,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456696:/24h [Temporal Concept]
   861   C1442770:24H [Temporal Concept]

Phrase: "100ng/ml lipopolysaccharide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023810:Lipopolysaccharide [Lipid]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.47: 60h later, 50l of medium was removed and TNF secretion measured by Quantikine M Mouse TNF ELISA kit (R &D systems) as described in the manufacturer's protocol. 

Phrase: "60h later,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415602:60H [Gene or Genome]

Phrase: "50l of medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "TNF secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "measured by Quantikine M Mouse TNF ELISA kit (R &D systems"
Meta Candidates (Total=25; Excluded=2; Pruned=0; Remaining=23)
   754   C0694746:m r [Immunologic Factor,Pharmacologic Substance]
   754   C1363984:TNF-R [Gene or Genome]
   754   C1512018:M.D. [Intellectual Product]
   754   C1706001:TNF-R [Gene or Genome]
   738   C0014441:ELISA [Laboratory Procedure]
   738   C0025914:Mouse [Mammal]
   738   C0025929:mouse [Mammal]
   738   C0026809:Mouse [Mammal]
   738   C0205090:R- [Spatial Concept]
   738   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0441923:M+ [Intellectual Product]
   738   C0444706:Measured [Qualitative Concept]
   738   C0684010:R. [Professional or Occupational Group]
   738   C0812225:KIT [Medical Device]
   738   C1150635:KIT [Molecular Function]
   738   C1705212:Kit [Medical Device]
   738   C1705213:KIT [Medical Device]
   738   C2603358:R' [Clinical Attribute]
   738   C3273202:Kit [Manufactured Object]
   738   C3541902:MEASURED [Diagnostic Procedure]
   704 E C0079809:Measure [Quantitative Concept]
   704 E C0242485:Measure [Functional Concept]
   704   C0449913:System [Functional Concept]
   704   C1553451:System [Manufactured Object]
   704   C1704459:System [Medical Device]

Phrase: ")"

Phrase: "as"

Phrase: "described in the manufacturer's protocol."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0442711:Protocol [Intellectual Product]
   760   C0947322:Manufacturer [Intellectual Product]
   760   C1507394:Protocol [Intellectual Product]
   760   C1522729:Protocol [Intellectual Product]
   760   C1552738:described [Idea or Concept]
   760   C1705426:Manufacturer [Population Group]
   760   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.48: Promoter-reporter Assay-- To detect the pathway activated in the presence of apoE peptide, we utilized the Mercury Pathway Profiling Systems (CLONTECH). 

Phrase: "Promoter-reporter Assay"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0243073:assay [Qualitative Concept]
   827   C0335038:Reporter [Professional or Occupational Group]
   827   C1510438:Assay [Laboratory Procedure]
   827   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   827   C1705915:Reporter [Conceptual Entity]
   827   C1709908:Reporter [Group]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "activated in the presence of apoE peptide,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1412481:APOE [Gene or Genome]
   748   C1879547:Activated [Activity]
   714 E C1515877:Activate [Functional Concept]

Phrase: "we"

Phrase: "utilized"

Phrase: "the Mercury Pathway Profiling Systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   729 E C0205373:Systemic [Functional Concept]

Phrase: "(CLONTECH"

Phrase: ")."
Processing 00000000.tx.49: Briefly, rat hippocampal neurons were cultured in 6-well dishes, transiently transfected with promoter-reporter plasmids using LipofectAMINE 2000(Life Technologies, Inc.) 

Phrase: "Briefly,"

Phrase: "rat hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "cultured in 6-well dishes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]
   726   C0010453:Culture [Idea or Concept]
   726   C0020498:DISH [Disease or Syndrome]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "transiently"

Phrase: "transfected with promoter-reporter plasmids"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0335038:Reporter [Professional or Occupational Group]
   760   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   760   C1705915:Reporter [Conceptual Entity]
   760   C1709908:Reporter [Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "LipofectAMINE 2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1312445:lipofectamine 2000 [Organic Chemical]
   861   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc."

Phrase: ")"
Processing 00000000.tx.50: as described in the manufacturer's protocol. 

Phrase: "as"

Phrase: "described in the manufacturer's protocol."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0442711:Protocol [Intellectual Product]
   760   C0947322:Manufacturer [Intellectual Product]
   760   C1507394:Protocol [Intellectual Product]
   760   C1522729:Protocol [Intellectual Product]
   760   C1552738:described [Idea or Concept]
   760   C1705426:Manufacturer [Population Group]
   760   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.51: These plasmids contained the secreted alkaline phosphatase (SEAP) reporter gene downstream of several copies of specific transcription factors binding sequences such as AP1, CRE, HSE, Myc, NFB, and serum response element. 

Phrase: "These plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the secreted alkaline phosphatase (SEAP) reporter gene downstream of several copies of specific transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0206414:Reporter Gene [Gene or Genome]
   747   C0040649:Gene Transcription [Genetic Function]
   744   C0812327:Transcription Factor Gene [Gene or Genome]
   734   C0017337:Gene [Gene or Genome]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "sequences such as AP1,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0162326:Sequences [Nucleotide Sequence]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]

Phrase: "CRE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511573:CRE [Gene or Genome]

Phrase: "HSE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1537381:HSE [Gene or Genome]
  1000   C3540642:HSE [Gene or Genome]

Phrase: "Myc,"

Phrase: "NFB,"

Phrase: "and"

Phrase: "serum response element."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0969709:Serum Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0229671:Serum [Body Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
Processing 00000000.tx.52: Transfected neurons were allowed to recover for 24h before 2M apoE peptide was added to the media. 

Phrase: "Transfected neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recover for 24h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0456696:/24h [Temporal Concept]
   790   C0521108:recover [Qualitative Concept]
   790   C1442770:24H [Temporal Concept]
   790   C2004454:recover [Organism Function]

Phrase: "before 2M apoE peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "added to the media."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1524062:Added [Functional Concept]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C1883712:Add [Functional Concept]
   737 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.53: Alkaline phosphatase activities in the media, at indicated times after addition of apoE peptide, were measured using Great EscApe SEAP Chemiluminescence Detection Kit (CLONTECH) following the manufacturer's protocol. 

Phrase: "Alkaline phosphatase activities in the media,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   799   C1149888:alkaline phosphatase activity [Molecular Function]
   790   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   773   C1149880:phosphatase activity [Molecular Function]
           phosphatase
   753   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0441655:Activities [Activity]
   753   C1979842:Alkaline [Qualitative Concept]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "at indicated times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "after addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of apoE peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Great EscApe SEAP Chemiluminescence Detection Kit (CLONTECH"

Phrase: ")"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the manufacturer's protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.54: Western Blot Analysis-- Cells were cultured in 6-well dishes, washed three times with PBS, and lysed with 200l of lysis buffer (50mM Tris-HCl, pH 8.0,20mM EDTA, 1% SDS, and 100mM NaCl). 

Phrase: "Western Blot Analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "--"

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in 6-well dishes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]
   726   C0010453:Culture [Idea or Concept]
   726   C0020498:DISH [Disease or Syndrome]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with PBS,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "lysed with 200l of lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0024348:Lysis [Pathologic Function]
           lysed
   753   C1536403:lysis [Cell Function]

Phrase: "(50mM Tris-HCl,"

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "20mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1% SDS,"

Phrase: "and"

Phrase: "100mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.55: 20-g samples were boiled for 5min, electrophoresed on 12.5% SDS-polyacrylamide electrophoresis gels and transferred onto Immobilon membrane (Millipore Corp., Bedford, MA). 

Phrase: "20-g samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "boiled for 5min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0242301:Boil [Disease or Syndrome]
   756   C1546559:Boil [Intellectual Product]

Phrase: "electrophoresed on 12.5% SDS-polyacrylamide electrophoresis gels"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   807   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   778   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   767   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   754   C0596607:electrophoresis gel [Laboratory Procedure]
   754   C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   744   C0013855:Electrophoresis [Laboratory Procedure]
           electrophorese
   744   C0017243:Gels [Biomedical or Dental Material]
   744   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   711 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "transferred onto Immobilon membrane"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0025255:Membrane [Tissue]
   770   C0063412:Immobilon [Organic Chemical,Pharmacologic Substance]
   770   C0348011:transferred [Functional Concept]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "(Millipore Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "Bedford,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.56: The membrane was incubated in blocking buffer (1PBS, 5% nonfat dried milk) for 1h at room temperature and then probed with a primary antibody in blocking buffer overnight at 4C. 

Phrase: "The membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "incubated in blocking buffer"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "(1PBS,"

Phrase: "5% nonfat dried milk"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   861   C0452721:Dried milk [Food]
   812   C0026131:Milk [Body Substance]
   812   C0349374:Milk [Food]
   812   C0444318:Milk [Substance]
   812   C1512080:Dried [Qualitative Concept]
   812   C2825079:Milk [Food]
   812   C2827485:Dried [Body Substance]
   779 E C0011682:Dry [Natural Phenomenon or Process]
   779 E C0205222:Dry [Qualitative Concept]
   756 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   756 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   741 E C0443260:Milky [Finding]

Phrase: ")"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "probed with a primary antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "in blocking buffer overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.57: After four washes in PBS containing 0.3% Tween 20,blots were probed with the secondary antibody in blocking buffer for 1h at room temperature, and washed again in PBS containing 0.05% Tween 20.

Phrase: "After four washes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Wash [Activity]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.3% Tween 20,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "blots"

Phrase: "were"

Phrase: "probed with the secondary antibody"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0027627:secondary [Neoplastic Process]
   760   C0175668:Secondary [Temporal Concept]
   760   C0205436:Secondary [Quantitative Concept]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "in blocking buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "again in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.05% Tween 20."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.58: Detection of signal was performed with an enhanced chemiluminescence detection kit (Amersham International, Little Chalfont, United Kingdom). 

Phrase: "Detection of signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0206100:Signal Detection [Mental Process]
   790   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed with an enhanced chemiluminescence detection kit (Amersham International, Little Chalfont,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   738   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   738   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   738   C0700321:Little [Quantitative Concept]
   738   C0812225:KIT [Medical Device]
   738   C0884358:Performed [Functional Concept]
   738   C1150635:KIT [Molecular Function]
   738   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   738   C1511790:Detection [Therapeutic or Preventive Procedure]
   738   C1512888:International [Idea or Concept]
   738   C1705212:Kit [Medical Device]
   738   C1705213:KIT [Medical Device]
   738   C2349975:Enhanced [Activity]
   738   C2700395:Little [Quantitative Concept]
   738   C3273202:Kit [Manufactured Object]
   704 E C2947996:Perform [Pharmacologic Substance]

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: ")."
Processing 00000000.tx.59: Protein Quantification-- The amount of protein (CREB, ERK, phosphorylated CREB, phosphorylated ERK, c-fos, Bcl-2, and actin) was quantified by scanning the density of immunodetected bands on Immobilon membrane using ImageQuant software (Molecular Dynamics, Sunnyvale, CA). 

Phrase: "Protein Quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709793:Quantification [Quantitative Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The amount of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "(CREB,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "ERK,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   979   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   979   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0521119:Extracellular [Cell Component]
   812   C0851285:Regulated [Governmental or Regulatory Activity]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "phosphorylated CREB,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "phosphorylated ERK,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   916   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   916   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0521119:Extracellular [Cell Component]
   804   C0851285:Regulated [Governmental or Regulatory Activity]
   804   C1710082:Signal [Phenomenon or Process]

Phrase: "c-fos,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085301:c fos [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0085940:c fos [Gene or Genome]
  1000   C0087140:c-fos [Gene or Genome]

Phrase: "Bcl-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "and"

Phrase: "actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "quantified by scanning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034606:Scanning [Diagnostic Procedure]
   790   C0441633:Scanning [Diagnostic Procedure]
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "the density of immunodetected bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0178587:density [Quantitative Concept]

Phrase: "on Immobilon membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ImageQuant software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Molecular Dynamics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: "Sunnyvale,"

Phrase: "CA)."
Processing 00000000.tx.60: Measurement of Intracellular Calcium Levels-- Fura-2 AM (Molecular probes, Eugene, OR) and an Argus 50/CA system (Hamamatsu Photonics, Japan) were used to quantify the cytoplasmic free calcium as described in the manufacturer's protocol.  

Phrase: "Measurement of Intracellular Calcium Levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0201925:Calcium measurement [Laboratory Procedure]
   760   C0242485:Measurement [Functional Concept]

Phrase: "--"

Phrase: "Fura-2 AM (Molecular probes,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   804   C0182400:Probes [Medical Device]
   771 E C1704681:Probe [Gene or Genome]
   771 E C2347609:Probe [Chemical Viewed Functionally]
   771 E C3536729:Probe [Manufactured Object]
   717   C0060845:fura-2-am [Organic Chemical,Pharmacologic Substance]

Phrase: "Eugene,"

Phrase: "OR)"

Phrase: "and"

Phrase: "an Argus 50/CA system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(Hamamatsu Photonics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328817:Photonics [Classification]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "the cytoplasmic free calcium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0596235:Free Calcium [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in the manufacturer's protocol."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0442711:Protocol [Intellectual Product]
   760   C0947322:Manufacturer [Intellectual Product]
   760   C1507394:Protocol [Intellectual Product]
   760   C1522729:Protocol [Intellectual Product]
   760   C1552738:described [Idea or Concept]
   760   C1705426:Manufacturer [Population Group]
   760   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.61: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Recombinant ApoE4 and Recombinant ApoE3 Were Equally Active in Suppressing the Secretion of TNF from Astrocytes-- The recombinant apoE4 and apoE3 proteins used for this study were not degraded as determined by Western blot analysis of denatured and reduced apoE proteins (Fig. 1A). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Recombinant ApoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   861   C2984964:APOE4 [Laboratory Procedure]

Phrase: "and"

Phrase: "Recombinant ApoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "Were"

Phrase: "Equally Active in Suppressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205177:Active [Functional Concept]

Phrase: "the Secretion of TNF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "from Astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "-"

Phrase: "-"

Phrase: "The recombinant apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   861   C2984964:APOE4 [Laboratory Procedure]

Phrase: "and"

Phrase: "apoE3 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "used for this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "as"

Phrase: "determined by Western blot analysis of denatured"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "reduced apoE proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.62: To show that these recombinant proteins also retained biological activity, we examined whether they equally inhibited the secretion of TNF from astrocytes as described by Laskowitz et al. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "these recombinant proteins also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0034861:Recombinant Proteins [Amino Acid, Peptide, or Protein]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1514798:recombinant [Organism]

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "biological activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205177:Activity [Functional Concept]
   861   C0205460:biological [Qualitative Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "they equally"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the secretion of TNF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "from astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "as"

Phrase: "described by Laskowitz et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.63: (20). 

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.64: Preincubation of primary astrocytes cultures prepared from neonatal apoE-deficient mice with recombinant apoE3 or with recombinant apoE4, prior to stimulation with 100ng/ml lipopolysaccharide, each decreased the concentration of TNF released into the conditioned medium in a dose-dependent fashion as compared with untreated cells (Fig. 1B). 

Phrase: "Preincubation of primary astrocytes"

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "prepared from neonatal apoE-deficient mice"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011155:Deficient [Functional Concept]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]
   753   C1552240:Neonatal [Professional or Occupational Group]
   753   C1552264:Neonatal [Professional or Occupational Group]
   753   C1636779:% deficient [Quantitative Concept]
   753   C2939425:Neonatal [Temporal Concept]
   719   C1521827:Prepare [Functional Concept]

Phrase: "with recombinant apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "or with recombinant apoE4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   770   C1514798:recombinant [Organism]
   770   C2984964:APOE4 [Laboratory Procedure]

Phrase: "prior to stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with 100ng/ml lipopolysaccharide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023810:Lipopolysaccharide [Lipid]

Phrase: "each"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the concentration of TNF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "released into the conditioned medium"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   806   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0009647:Conditioned [Mental Process]
   760   C0391871:Released [Functional Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C1283071:Released [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "in a dose-dependent fashion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "as"

Phrase: "compared with untreated cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0332155:untreated [Finding]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.65: There was no significant difference in TNF levels between cells treated with the same concentration of apoE3 or apoE4. 

Phrase: "There"

Phrase: "was"

Phrase: "no significant difference in TNF levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "between cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with the same concentration of apoE3"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]
   748   C0086045:Concentration [Mental Process]
   748   C0445247:Same [Qualitative Concept]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "apoE4."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]
Processing 00000000.tx.66: Boiled and denatured apoE3 was used as control protein and it did not suppress the secretion of TNF. 

Phrase: "Boiled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0242301:Boil [Disease or Syndrome]
   966   C1546559:Boil [Intellectual Product]

Phrase: "and"

Phrase: "denatured apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "used as control protein"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "it"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "the secretion of TNF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
Processing 00000000.tx.67: View larger version (9K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.68: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.69: Characterization of recombinant apoE3 and apoE4. 

Phrase: "Characterization of recombinant apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "apoE4."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]
Processing 00000000.tx.70: 5ng of recombinant apoE3 and apoE4 were electrophoresed on denaturing and reducing polyacrylamide gels, Western blotted, and probed with anti-apolipoprotein E antibody, demonstrating that both are not degraded (A). 

Phrase: "5ng of recombinant apoE3"

Phrase: "and"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "were"

Phrase: "electrophoresed on denaturing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0013855:electrophorese [Laboratory Procedure]

Phrase: "and"

Phrase: "reducing polyacrylamide gels,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   827   C0017243:Gels [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   793 E C1382104:Gel [Substance]

Phrase: "Western"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:Western [Spatial Concept]

Phrase: "blotted"

Phrase: ","

Phrase: "and"

Phrase: "probed with anti-apolipoprotein E antibody,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0313106:Anti e [Amino Acid, Peptide, or Protein,Immunologic Factor]
           antibody e
   783   C0947659:Anti E [Amino Acid, Peptide, or Protein,Immunologic Factor]
           antibody e
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719   C0182400:Probe [Medical Device]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719   C3536729:Probe [Manufactured Object]

Phrase: "demonstrating"

Phrase: "that"

Phrase: "both"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.71: Preincubation with recombinant apoE3 or apoE4 inhibited the secretion of TNF from astrocytes prepared from apoE-deficient mice in a dose-dependent fashion as compared with heat-denatured apoE3. 

Phrase: "Preincubation with recombinant apoE3"

Phrase: "or"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the secretion of TNF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "from astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "prepared from apoE-deficient mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011155:Deficient [Functional Concept]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0523511:APOE [Laboratory Procedure]
   760   C1412481:APOE [Gene or Genome]
   760   C1636779:% deficient [Quantitative Concept]
   726   C1521827:Prepare [Functional Concept]

Phrase: "in a dose-dependent fashion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "as"

Phrase: "compared with heat-denatured apoE3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0018837:Heat [Natural Phenomenon or Process]
   760   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.72: The difference between apoE3 and apoE4 was not significant at any concentration (Student's t test). 

Phrase: "The difference between apoE3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "was"

Phrase: "not significant at any concentration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1273937:Not significant [Finding]
   760   C0237881:significant [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]

Phrase: "(Student's t test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.73: All results are plotted as a meanS.E. of four data (B). 

Phrase: "All results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "plotted as a meanS.E. of four data"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0205450:Four [Quantitative Concept]
   744   C1511726:Data [Idea or Concept]
   744   C1704970:Means [Conceptual Entity]
   744   C3245479:data [Medical Device]
   711 E C0444504:Mean [Quantitative Concept]
   711 E C2347634:Mean [Quantitative Concept]
   711 E C2348143:Mean [Quantitative Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.74: ApoE Peptide Facilitates CRE-driven Transcription-- To detect the signaling pathway activated in the presence of apoE peptide, we utilized the Mercury Pathway Profiling Systems (CLONTECH). 

Phrase: "ApoE Peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "Facilitates"

Phrase: "CRE-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511573:CRE [Gene or Genome]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "Transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the signaling pathway"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0037083:signaling pathway [Cell Function]
  1000   C0086982:Signaling Pathway [Molecular Function]
   983 E C0037080:Signal Pathway [Molecular Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "activated in the presence of apoE peptide,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1412481:APOE [Gene or Genome]
   748   C1879547:Activated [Activity]
   714 E C1515877:Activate [Functional Concept]

Phrase: "we"

Phrase: "utilized"

Phrase: "the Mercury Pathway Profiling Systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   729 E C0205373:Systemic [Functional Concept]

Phrase: "(CLONTECH"

Phrase: ")."
Processing 00000000.tx.75: Several cis-acting enhancer elements, such as AP1 (activator protein 1), CRE (cAMP responsive element), HSE (heat shock element), Myc, NFB (nuclear factor of B), and serum response element included in this system were assessed in rat primary hippocampal neurons exposed to 1M apoE peptide. 

Phrase: "Several cis-acting enhancer elements,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   877   C0599780:cis acting element [Nucleotide Sequence]
   840   C0014290:Enhancer Elements [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Elements [Element, Ion, or Isotope]
   771 E C1705248:Element [Conceptual Entity]

Phrase: "such as AP1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3536909:AP1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(activator protein 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0085828:Activator Protein-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812312:activator protein 1 [Gene or Genome]
  1000   C1333571:activator protein 1 [Gene or Genome]
  1000   C3536909:Activator Protein 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1419349:activator 1 [Gene or Genome]
   901   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "CRE (cAMP responsive element"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0205342:Responsive [Functional Concept]
   812   C1705248:Element [Conceptual Entity]
   741 E C2371924:Responsivity [Mental Process]

Phrase: ")"

Phrase: ","

Phrase: "HSE (heat shock element"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0282498:Heat Shock [Physiologic Function]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0018837:Heat [Natural Phenomenon or Process]
   812   C0036974:Shock [Pathologic Function]
   812   C1705248:Element [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "Myc,"

Phrase: "NFB"

Phrase: "(nuclear factor of B"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   819   C1824728:FACTOR B [Gene or Genome]
   770   C0521447:Nuclear [Spatial Concept]
   770   C1521761:Factor [Functional Concept]
   770   C2827422:Factor [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "serum response element"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0969709:Serum Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0229671:Serum [Body Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "included in this system"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0332257:included [Functional Concept]
   770   C0449913:System [Functional Concept]
   770   C1553451:System [Manufactured Object]
   770   C1704459:System [Medical Device]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "were"

Phrase: "assessed in rat primary hippocampal neurons"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   753   C0027882:Neurons [Cell]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C1516048:Assessed [Activity]

Phrase: "exposed to 1M apoE peptide."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0470296:1M [Quantitative Concept]
   760   C0523511:APOE [Laboratory Procedure]
   760   C1412481:APOE [Gene or Genome]
Processing 00000000.tx.76: Among these elements, transcription from the CRE element was found to be activated (Fig. 2). 

Phrase: "Among these elements,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013879:Elements [Element, Ion, or Isotope]
   966 E C1705248:Element [Conceptual Entity]

Phrase: "transcription from the CRE element"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040649:Transcription [Genetic Function]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.77: View larger version (18K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.78: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.79: ApoE-peptide treatment increases CREB-responsive reporter activity (transcriptional activity of CREB). 

Phrase: "ApoE-peptide treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "CREB-responsive reporter activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   850   C2266866:Binding Activity [Molecular Function]
   836   C1537044:protein activity [Molecular Function]
   793   C0205177:Activity [Functional Concept]
   793   C0439167:% activity [Quantitative Concept]
   793   C0441655:Activity [Activity]
   793   C1561536:*Activity [Idea or Concept]
   723   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(transcriptional activity of CREB"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C1537044:protein activity [Molecular Function]
   767   C2266866:Binding Activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
   703   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.80: A CRE-SEAP reporter plasmid containing three copies of CRE elements linked to a TATA-like promoter from the HSV-TK gene and fused to the SEAP gene (CLONTECH) was transfected into rat primary hippocampal neurons on day 7of in vitro culture using the LipofectAMINE 2000procedure (Life Technologies, Inc.). 

Phrase: "A CRE-SEAP reporter plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "three copies of CRE elements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1948062:Copies [Manufactured Object]

Phrase: "linked to a TATA-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "like promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "from the HSV-TK gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1333929:HSV-Tk Gene [Gene or Genome]
           HSV-Tk
   901   C1336633:TK Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0879457:HSVtk [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "fused to the SEAP gene"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   814   C1412365:SECRETED ALKALINE PHOSPHATASE [Gene or Genome]
   778   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   757   C1414861:FUSE gene [Gene or Genome]
       E   FUSE
   748   C0017337:Gene [Gene or Genome]
   748   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0699952:Fused [Functional Concept]
   748   C1149880:phosphatase [Molecular Function]
   748   C1327616:Secreted [Cell Function]
   748   C1979842:Alkaline [Qualitative Concept]
   714 E C1708111:Fuse [Manufactured Object]

Phrase: "(CLONTECH"

Phrase: ")"

Phrase: "was"

Phrase: "transfected into rat primary hippocampal neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   753   C0027882:Neurons [Cell]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]

Phrase: "on day 7of in vitro culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0010453:Culture [Idea or Concept]
   804   C0220814:culture [Functional Concept]
   804   C0430400:Culture [Laboratory Procedure]
   804   C2242979:Culture [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the LipofectAMINE 2000procedure"

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.81: The activity of SEAP measured as chemiluminescence (Great EscApe, CLONTECH) in the medium increased in a time-dependent fashion after treatment with 2M apoE peptide indicating that apoE peptide facilitates activation of the transcriptional activity of CREB. 

Phrase: "The activity of SEAP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   820   C1149888:alkaline phosphatase activity [Molecular Function]
   783   C1149880:phosphatase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "measured as chemiluminescence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   790   C0444706:Measured [Qualitative Concept]
   790   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "(Great EscApe,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0870509:escape [Mental Process]
   861   C1880554:ESCAPE [Event]

Phrase: "CLONTECH"

Phrase: ")"

Phrase: "in the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "increased in a time-dependent fashion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0040223:Time [Temporal Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "after treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with 2M apoE peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "indicating"

Phrase: "that apoE peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "facilitates"

Phrase: "activation of the transcriptional activity of CREB."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   788   C2245434:activation of protein binding [Molecular Function]
   772   C2259194:activation of binding [Molecular Function]
   754   C0162493:Transcriptional Activation [Genetic Function]
   754   C0599177:protein activation [Genetic Function]
   738   C1879547:Activation [Activity]
Processing 00000000.tx.82: Error bars represent the S.E. 

Phrase: "Error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the S.E."
Processing 00000000.tx.83: (n=6). 

Phrase: "(n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.84: *, p<0.05compared with time 0control using Student's t test. 

Phrase: "*,"

Phrase: "p<0.05compared with time 0control"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Student's t test."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]
Processing 00000000.tx.85: ApoE Peptide and ApoE4, but Not ApoE3, Facilitated Phosphorylation of CREB at Ser-133-- Since apoE peptide stimulated transcription from the CRE element, then the CREB transcription factor could be activated by apoE treatments. 

Phrase: "ApoE Peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "ApoE4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "but"

Phrase: "Not ApoE3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "Facilitated Phosphorylation of CREB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   744   C0031715:Phosphorylation [Molecular Function]
   703   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "at Ser-133"

Phrase: "-"

Phrase: "-"

Phrase: "Since"

Phrase: "apoE peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "transcription from the CRE element,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040649:Transcription [Genetic Function]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the CREB transcription factor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0040649:Transcription [Genetic Function]
   795   C1521761:Factor [Functional Concept]
   795   C2827422:Factor [Conceptual Entity]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C3158668:cAMP response element binding [Genetic Function]

Phrase: "could"

Phrase: "be"

Phrase: "activated by apoE treatments."
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0087111:Treatments [Therapeutic or Preventive Procedure]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]
   770   C1879547:Activated [Activity]
   737 E C0039798:treatment [Functional Concept]
   737 E C1515877:Activate [Functional Concept]
   737 E C1522326:Treatment [Functional Concept]
   737 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   737 E C1705169:Treatment [Conceptual Entity]
   737 E C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.86: Phosphorylation of CREB at Ser-133 leads to its activation as a transcription factor (21, 22). 

Phrase: "Phosphorylation of CREB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   748   C0031715:Phosphorylation [Molecular Function]
   731   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "at Ser-133"

Phrase: "leads to its activation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1879547:Activation [Activity]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "as a transcription factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "(21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.87: To monitor the activation of CREB directly, Western blots of cell lysates from rat hippocampal neurons stimulated with 1M apoE peptide for the indicated times were probed with anti-CREB and anti-phospho-CREB (p-CREB) antibodies. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "the activation of CREB directly,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C2245434:activation of protein binding [Molecular Function]
   784   C2259194:activation of binding [Molecular Function]
   762   C0599177:protein activation [Genetic Function]
   742   C1879547:Activation [Activity]

Phrase: "Western blots of cell lysates"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0949466:Western Blots [Laboratory Procedure]
   773 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C1705493:Western [Spatial Concept]

Phrase: "from rat hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "stimulated with 1M apoE peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0470296:1M [Quantitative Concept]
   760   C0523511:APOE [Laboratory Procedure]
   760   C1412481:APOE [Gene or Genome]
   760   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "for the indicated times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "were"

Phrase: "probed with anti-CREB"
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   869   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C3158668:cAMP response element binding [Genetic Function]
   800   C1511573:cAMP Response Element [Gene or Genome]
   770   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   767 E C0033618:Protein Binding [Molecular Function]
   767   C1148918:cAMP binding [Molecular Function]
   744   C0013879:Element [Element, Ion, or Isotope]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   744   C0243122:binding [Functional Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1704632:Response [Finding]
   744   C1705248:Element [Conceptual Entity]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]
   711   C0182400:Probe [Medical Device]
   711   C1704681:Probe [Gene or Genome]
   711   C2347609:Probe [Chemical Viewed Functionally]
   711   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "anti-phospho-CREB (p-CREB) antibodies."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   892   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   723   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.88: 15min after addition of apoE peptide, phospho-CREB levels substantially increased followed by a gradual decrease over the next 12h while the total amount of CREB did not appear to change (Fig. 3A). 

Phrase: "15min after addition of apoE peptide,"

Phrase: "phospho-CREB levels substantially"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   834   C1547597:Response level [Idea or Concept]
   793   C0441889:Levels [Qualitative Concept]
   779   C0428479:Protein level [Laboratory or Test Result]
   760 E C0456079:Level [Classification]
   760 E C1547707:Level [Geographic Area]
   760 E C2946261:Level [Pharmacologic Substance]
   723   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "followed by a gradual decrease"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0392756:Decrease [Qualitative Concept]
   760   C0439833:Gradual [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "over the next 12h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456695:/12h [Temporal Concept]

Phrase: "while"

Phrase: "the total amount of CREB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:Amount [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.89: In addition to apoE peptide, treatment with 1M apoE4 protein also appeared to significantly increase phospho-CREB levels by 1h after treatment, while 1M apoE3 protein did not appear to change phospho-CREB levels significantly at any time (Fig. 3, B-D). 

Phrase: "In addition to apoE peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "treatment with 1M apoE4 protein also"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "phospho-CREB levels by 1h"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   745   C1547597:Response level [Idea or Concept]
   742   C0441889:Levels [Qualitative Concept]
   731   C0428479:Protein level [Laboratory or Test Result]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "after treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "while"

Phrase: "1M apoE3 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "phospho-CREB levels significantly at any time"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   738   C0441889:Levels [Qualitative Concept]
   737   C1547597:Response level [Idea or Concept]
   722   C0428479:Protein level [Laboratory or Test Result]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D)."
Processing 00000000.tx.90: Although the molar concentration of apoE4 and apoE peptide added to the media was equivalent, the kinetics (time course) of CREB phosphorylation following treatment with apoE4 protein appeared to be slower than that stimulated by apoE peptide treatment. 

Phrase: "Although"

Phrase: "the molar concentration of apoE4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0026367:Molar [Body Part, Organ, or Organ Component]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "apoE peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "added to the media"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1524062:Added [Functional Concept]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C1883712:Add [Functional Concept]
   737 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "equivalent,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205163:Equivalent [Qualitative Concept]
  1000   C0439185:equivalent [Quantitative Concept]

Phrase: "the kinetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022702:Kinetics [Natural Phenomenon or Process]
  1000   C0220865:kinetics [Functional Concept]
  1000   C2825046:Kinetics [Occupation or Discipline]

Phrase: "(time course"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0449247:Time course [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C0750729:Course [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: ")"

Phrase: "of CREB phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   799   C0031715:Phosphorylation [Molecular Function]
   780   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C3158668:cAMP response element binding [Genetic Function]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment with apoE4 protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "slower than that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0439834:Slow [Qualitative Concept]

Phrase: "stimulated by apoE peptide treatment."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0523511:APOE [Laboratory Procedure]
   760   C1412481:APOE [Gene or Genome]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C1948023:Stimulated [Natural Phenomenon or Process]
   760   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.91: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.92: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.93: Treatment with apoE4 or apoE-peptide increases phospho-CREB levels. 

Phrase: "Treatment with apoE4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "or"

Phrase: "apoE-peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "phospho-CREB levels."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   845   C1547597:Response level [Idea or Concept]
   795   C0441889:Levels [Qualitative Concept]
   785   C0428479:Protein level [Laboratory or Test Result]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C3158668:cAMP response element binding [Genetic Function]
Processing 00000000.tx.94: Rat hippocampal neurons at day 7in culture were treated with 2M apoE peptide (A), 2M apoE3 (B), or 2M apoE4 (C) for the indicated times. 

Phrase: "Rat hippocampal neurons at day 7in culture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0027882:Neurons [Cell]

Phrase: "were"

Phrase: "treated with 2M apoE peptide"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0523511:APOE [Laboratory Procedure]
   760   C1412481:APOE [Gene or Genome]
   760   C1522326:Treated [Functional Concept]
   760   C3171718:2M [Quantitative Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "2M apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "2M apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   861   C2984964:APOE4 [Laboratory Procedure]

Phrase: "(C) for the indicated times."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0719058:C-Time [Organic Chemical,Pharmacologic Substance,Vitamin]
   760   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.95: Cell lysates (20g/lane) were electrophoresed on SDS-PAGE, Western blotted, and probed with anti-phospho-CREB antibody or anti-CREB antibody. 

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(20g/lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "electrophoresed on SDS-PAGE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0013855:electrophorese [Laboratory Procedure]

Phrase: "Western"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:Western [Spatial Concept]

Phrase: "blotted"

Phrase: ","

Phrase: "and"

Phrase: "probed with anti-phospho-CREB antibody"
Meta Candidates (Total=27; Excluded=1; Pruned=0; Remaining=26)
   833   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C3158668:cAMP response element binding [Genetic Function]
   782   C1511573:cAMP Response Element [Gene or Genome]
   760   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0003261:Antibody Response [Biologic Function]
   757 E C0033618:Protein Binding [Molecular Function]
   757   C1148918:cAMP binding [Molecular Function]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0013879:Element [Element, Ion, or Isotope]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   739   C0243122:binding [Functional Concept]
   739   C0871261:Response [Organism Attribute]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1704632:Response [Finding]
   739   C1705248:Element [Conceptual Entity]
   739   C1706817:Response [Intellectual Product]
   739   C2911692:Response [Mental Process]
   706   C0182400:Probe [Medical Device]
   706   C1704681:Probe [Gene or Genome]
   706   C2347609:Probe [Chemical Viewed Functionally]
   706   C3536729:Probe [Manufactured Object]

Phrase: "or"

Phrase: "anti-CREB antibody."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   893   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C3158668:cAMP response element binding [Genetic Function]
Processing 00000000.tx.96: The amount of phosphorylated CREB and total CREB was quantified by scanning densitometry of immunoreactive bands. 

Phrase: "The amount of phosphorylated CREB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "total CREB"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   895   C0555903:Total protein [Laboratory Procedure]
   895   C1261360:total protein [Laboratory or Test Result]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "quantified by scanning densitometry of immunoreactive bands."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0011321:Densitometry [Laboratory Procedure]
           densitometric scanning
   748   C0034606:Scanning [Diagnostic Procedure]
   748   C0175723:Bands [Medical Device]
   748   C0441633:Scanning [Diagnostic Procedure]
   714 E C0439645:Band [Spatial Concept]
   714 E C1521913:band [Cell Component]
   714   C1709793:Quantify [Quantitative Concept]
   714 E C2826292:SCAN [Finding]
Processing 00000000.tx.97: The ratios of phosphorylated CREB to total CREB are plotted as a meanS.E. of at least four separate experiments. 

Phrase: "The ratios of phosphorylated CREB"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0456603:Ratios [Quantitative Concept]
   742   C1610540:*Ratios [Quantitative Concept]
   708 E C1547037:Ratio [Intellectual Product]

Phrase: "to total CREB"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   895   C0555903:Total protein [Laboratory Procedure]
   895   C1261360:total protein [Laboratory or Test Result]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "are"

Phrase: "plotted as a meanS.E. of"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C1704970:Means [Conceptual Entity]
   719 E C0444504:Mean [Quantitative Concept]
   719 E C2347634:Mean [Quantitative Concept]
   719 E C2348143:Mean [Quantitative Concept]

Phrase: "at least four separate experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.98: *, p<0.05compared with unstimulated control using Student's t test (A and D). 

Phrase: "*,"

Phrase: "p<0.05compared with unstimulated control"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Student's t test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "(A"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.99: **, p<0.05using Student's t test. 

Phrase: "*"

Phrase: "*,"

Phrase: "p<0.05using Student's t test."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0022885:Test [Laboratory Procedure]
   799   C0038492:student [Professional or Occupational Group]
   799   C0039593:Test [Functional Concept]
   799   C0392366:test [Intellectual Product]
   799   C1551041:student [Idea or Concept]
   799   C1552573:student [Intellectual Product]
Processing 00000000.tx.100: apoE4>apoE3 (D). 

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: ">apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.101: ApoE Peptide and ApoE4, but Not ApoE3, Facilitated ERK Activity in Rat Hippocampal Neurons-- Since activated CREB is phosphorylated at Ser-133 and apoE treatment increases levels of phosphorylated CREB, then apoE may stimulate a pathway resulting in kinase-mediated phosphorylation of CREB. 

Phrase: "ApoE Peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "ApoE4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "but"

Phrase: "Not ApoE3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "Facilitated"

Phrase: "ERK Activity in Rat Hippocampal Neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   849   C2261587:extracellular signal-regulated kinase activity [Molecular Function]
   764   C1150423:kinase activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "--"

Phrase: "Since activated CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   913   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   877   C3158668:cAMP response element binding [Genetic Function]
   845   C1148918:cAMP binding [Molecular Function]
   845   C1511573:cAMP Response Element [Gene or Genome]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0013879:Element [Element, Ion, or Isotope]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   795   C0243122:binding [Functional Concept]
   795   C0871261:Response [Organism Attribute]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1704632:Response [Finding]
   795   C1705248:Element [Conceptual Entity]
   795   C1706817:Response [Intellectual Product]
   795   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "phosphorylated at Ser-133"

Phrase: "and"

Phrase: "apoE treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "levels of phosphorylated CREB,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   750   C0428479:Protein level [Laboratory or Test Result]
   750   C1547597:Response level [Idea or Concept]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]
   703   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "then apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "may"

Phrase: "stimulate"

Phrase: "a pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "resulting in kinase-mediated phosphorylation"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0332294:Resulting in [Functional Concept]
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0678226:resulting [Functional Concept]
   760   C1158886:Phosphorylation [Molecular Function]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "of CREB."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]
Processing 00000000.tx.102: One candidate for CREB phosphorylation at Ser-133 is through the ERK pathway that is activated by a double phosphorylation of ERK at Thr-202 and Tyr-204. 

Phrase: "One candidate for CREB phosphorylation"

Phrase: "at Ser-133"

Phrase: "is through the ERK pathway"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   812   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0037080:Signal Pathway [Molecular Function]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0521119:Extracellular [Cell Component]
   744   C0851285:Regulated [Governmental or Regulatory Activity]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]
   744   C1710082:Signal [Phenomenon or Process]

Phrase: "that"

Phrase: "is"

Phrase: "activated by a double phosphorylation of ERK"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   785   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   785   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205173:Double [Functional Concept]
   739   C0521119:Extracellular [Cell Component]
   739   C0851285:Regulated [Governmental or Regulatory Activity]
   739   C1158886:Phosphorylation [Molecular Function]
   739   C1705764:Double [Activity]
   739   C1705765:Double [Qualitative Concept]
   739   C1710082:Signal [Phenomenon or Process]
   739   C1879547:Activated [Activity]
   706 E C1515877:Activate [Functional Concept]

Phrase: "at Thr-202"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Tyr-204."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]
Processing 00000000.tx.103: We examined ERK activation by measuring phosphorylated ERK levels following treatment with apoE peptide, apoE3, and apoE4 proteins. 

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "ERK activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1879547:Activation [Activity]
   750   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   750   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "by measuring phosphorylated ERK levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   795   C0441889:Levels [Qualitative Concept]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment with apoE peptide,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "apoE3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "apoE4 proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.104: Treatment with apoE peptide or with apoE4 protein resulted in significantly increased levels of phosphorylated ERK while apoE3 treatment failed to increase levels (Fig. 4). 

Phrase: "Treatment with apoE peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "or with apoE4 protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   770   C2984964:APOE4 [Laboratory Procedure]

Phrase: "resulted in significantly increased levels of phosphorylated ERK"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   776   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   776   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0205217:Increased [Quantitative Concept]
   738   C0441889:Levels [Qualitative Concept]
   738   C0442805:Increased [Functional Concept]
   738   C0521119:Extracellular [Cell Component]
   738   C0851285:Regulated [Governmental or Regulatory Activity]
   738   C1710082:Signal [Phenomenon or Process]
   704 E C0456079:Level [Classification]
   704   C1274040:Result [Functional Concept]
   704   C1546471:Result [Idea or Concept]
   704 E C1547707:Level [Geographic Area]
   704   C2825142:Result [Finding]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "while"

Phrase: "apoE3 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.105: ApoE peptide increased phospho-ERK levels by 15min of treatment while apoE4 protein increased them by 1h of treatment. 

Phrase: "ApoE peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "phospho-ERK levels by 15min of treatment"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "while"

Phrase: "apoE4 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "them by 1h of treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1442450:1H [Temporal Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.106: Like the phosphorylation of CREB, phosphorylation of ERK following apoE4 protein treatment appeared to be slower than that following apoE peptide treatment. 

Phrase: "Like the phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of CREB,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "phosphorylation of ERK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "apoE4 protein treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "slower than that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0439834:Slow [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "apoE peptide treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.107: View larger version (24K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.108: 4.  

Phrase: "4."
Processing 00000000.tx.109: Treatment with apoE4 or apoE-peptide increases phosphorylated ERK levels. 

Phrase: "Treatment with apoE4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "or"

Phrase: "apoE-peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "phosphorylated ERK levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   713   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   713   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.110: Rat hippocampal neurons at day 7in culture were treated with 2M apoE-peptide (A), 2M apoE3 (B), or 2M apoE4 (C) for the indicated times. 

Phrase: "Rat hippocampal neurons at day 7in culture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0027882:Neurons [Cell]

Phrase: "were"

Phrase: "treated with 2M apoE-peptide"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0523511:APOE [Laboratory Procedure]
   760   C1412481:APOE [Gene or Genome]
   760   C1522326:Treated [Functional Concept]
   760   C3171718:2M [Quantitative Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "2M apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "2M apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   861   C2984964:APOE4 [Laboratory Procedure]

Phrase: "(C) for the indicated times."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0719058:C-Time [Organic Chemical,Pharmacologic Substance,Vitamin]
   760   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.111: Cell lysates (20g/lane) were electrophoresed on SDS-PAGE, Western blotted, and probed with anti-phospho-ERK antibody or anti-ERK antibody. 

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(20g/lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "electrophoresed on SDS-PAGE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0013855:electrophorese [Laboratory Procedure]

Phrase: "Western"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:Western [Spatial Concept]

Phrase: "blotted"

Phrase: ","

Phrase: "and"

Phrase: "probed with anti-phospho-ERK antibody"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   797   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0521119:Extracellular [Cell Component]
   742   C0851285:Regulated [Governmental or Regulatory Activity]
   742   C1710082:Signal [Phenomenon or Process]
   708   C0182400:Probe [Medical Device]
   708   C1704681:Probe [Gene or Genome]
   708   C2347609:Probe [Chemical Viewed Functionally]
   708   C3536729:Probe [Manufactured Object]

Phrase: "or"

Phrase: "anti-ERK antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   895   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   713   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   713   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.112: The amount of phosphorylated ERK and total ERK was quantified by scanning densitometry of immunoreactive bands. 

Phrase: "The amount of phosphorylated ERK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "total ERK"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   916   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   916   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0521119:Extracellular [Cell Component]
   804   C0851285:Regulated [Governmental or Regulatory Activity]
   804   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "quantified by scanning densitometry of immunoreactive bands."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0011321:Densitometry [Laboratory Procedure]
           densitometric scanning
   748   C0034606:Scanning [Diagnostic Procedure]
   748   C0175723:Bands [Medical Device]
   748   C0441633:Scanning [Diagnostic Procedure]
   714 E C0439645:Band [Spatial Concept]
   714 E C1521913:band [Cell Component]
   714   C1709793:Quantify [Quantitative Concept]
   714 E C2826292:SCAN [Finding]
Processing 00000000.tx.113: The ratios of phosphorylated ERK to total ERK are plotted as a meanS.E. of four separate experiments. 

Phrase: "The ratios of phosphorylated ERK"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0456603:Ratios [Quantitative Concept]
   744   C1610540:*Ratios [Quantitative Concept]
   711 E C1547037:Ratio [Intellectual Product]

Phrase: "to total ERK"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   916   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   916   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0521119:Extracellular [Cell Component]
   804   C0851285:Regulated [Governmental or Regulatory Activity]
   804   C1710082:Signal [Phenomenon or Process]

Phrase: "are"

Phrase: "plotted as a meanS.E. of four separate experiments."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   742   C0205450:Four [Quantitative Concept]
   742   C0443299:Separate [Spatial Concept]
   742   C0681814:Experiments [Research Activity]
   742   C1704970:Means [Conceptual Entity]
   708 E C0444504:Mean [Quantitative Concept]
   708 E C1706386:Experiment [Conceptual Entity]
   708 E C2347634:Mean [Quantitative Concept]
   708 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.114: *, p<0.05compared with unstimulated control using Student's t test (A, D); 

Phrase: "*,"

Phrase: "p<0.05compared with unstimulated control"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Student's t test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "(A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "D)"

Phrase: ";"
Processing 00000000.tx.115: **, apoE4>apoE3, p<0.05using Student's t test; 

Phrase: "*"

Phrase: "*,"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: ">apoE3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "p<0.05using Student's t test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0022885:Test [Laboratory Procedure]
   799   C0038492:student [Professional or Occupational Group]
   799   C0039593:Test [Functional Concept]
   799   C0392366:test [Intellectual Product]
   799   C1551041:student [Idea or Concept]
   799   C1552573:student [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.116: ***, apoE4<apoE3 (D). 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "<apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.117: ApoE Peptide Facilitated the Expression of c-fos and Bcl-2 in Rat Hippocampal Neurons-- To confirm that the apoE peptide stimulated phosphorylation that resulted in increased functional activity of CREB, we examined whether apoE peptide treatment led to transactivation of the CRE-dependent genes, c-fos and Bcl-2. 

Phrase: "ApoE Peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "Facilitated"

Phrase: "the Expression of c-fos"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Bcl-2 in Rat Hippocampal Neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0376515:Bcl-2 [Gene or Genome]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the apoE peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "that"

Phrase: "resulted in increased functional activity of CREB,"
Meta Candidates (Total=33; Excluded=1; Pruned=0; Remaining=32)
   820   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C3158668:cAMP response element binding [Genetic Function]
   775   C1511573:cAMP Response Element [Gene or Genome]
   756   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   754 E C0033618:Protein Binding [Molecular Function]
   754   C0474395:increased activity [Finding]
   754   C1148918:cAMP binding [Molecular Function]
   754   C1537044:protein activity [Molecular Function]
   754   C2266866:Binding Activity [Molecular Function]
   738   C0013879:Element [Element, Ion, or Isotope]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   738   C0205177:Activity [Functional Concept]
   738   C0205217:Increased [Quantitative Concept]
   738   C0205245:Functional [Functional Concept]
   738   C0243122:binding [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C0442805:Increased [Functional Concept]
   738   C0542341:Functional [Functional Concept]
   738   C0871261:Response [Organism Attribute]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1561536:*Activity [Idea or Concept]
   738   C1704632:Response [Finding]
   738   C1705248:Element [Conceptual Entity]
   738   C1706817:Response [Intellectual Product]
   738   C2700217:Functional [Conceptual Entity]
   738   C2911692:Response [Mental Process]
   704   C1274040:Result [Functional Concept]
   704   C1546471:Result [Idea or Concept]
   704   C2825142:Result [Finding]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "apoE peptide treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "led to transactivation of the CRE-dependent genes,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   744   C0017337:Genes [Gene or Genome]
   744   C0040624:Transactivation [Genetic Function]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1511573:CRE [Gene or Genome]
   744   C1701901:Dependent [Qualitative Concept]
   744   C1708698:LED [Manufactured Object]
   744   C3244310:dependent [Functional Concept]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1522538:Lead [Functional Concept]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "c-fos"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085301:c fos [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0085940:c fos [Gene or Genome]
  1000   C0087140:c-fos [Gene or Genome]

Phrase: "and"

Phrase: "Bcl-2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]
Processing 00000000.tx.118: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.119: 5, increased levels of both c-fos and Bcl-2 result from treatment with apoE peptide, whereas the level of a control protein, actin, does not appear to increase. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "increased levels of both c-fos"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "Bcl-2 result from treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "with apoE peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "whereas"

Phrase: "the level of a control protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0428479:Protein level [Laboratory or Test Result]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "actin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.120: View larger version (31K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.121: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.122: Treatment with apoE-peptide increases c-fos and Bcl-2 levels. 

Phrase: "Treatment with apoE-peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "c-fos"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085301:c fos [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0085940:c fos [Gene or Genome]
  1000   C0087140:c-fos [Gene or Genome]

Phrase: "and"

Phrase: "Bcl-2 levels."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0376515:Bcl-2 [Gene or Genome]
Processing 00000000.tx.123: Rat hippocampal neurons at day 7of culture were treated with 2M apoE-peptide for the indicated times. 

Phrase: "Rat hippocampal neurons at day 7of culture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0027882:Neurons [Cell]

Phrase: "were"

Phrase: "treated with 2M apoE-peptide"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0523511:APOE [Laboratory Procedure]
   760   C1412481:APOE [Gene or Genome]
   760   C1522326:Treated [Functional Concept]
   760   C3171718:2M [Quantitative Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "for the indicated times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.124: Cell lysates were electrophoresed, Western blotted, and probed with anti-c-fos antibody (A), anti-Bcl-2 antibody (B), or anti-actin antibody as a control. 

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "electrophoresed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013855:electrophorese [Laboratory Procedure]

Phrase: ","

Phrase: "Western"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:Western [Spatial Concept]

Phrase: "blotted"

Phrase: ","

Phrase: "and"

Phrase: "probed with anti-c-fos antibody (A),"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   820   C0051967:anti-c antibody [Immunologic Factor]
   790   C0432624:Anti C [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0432626:Anti c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0368815:antibody c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719   C0182400:Probe [Medical Device]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719   C3536729:Probe [Manufactured Object]

Phrase: "anti-Bcl-2 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "anti-actin antibody as a control."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.125: (C) *, p<0.05compared with unstimulated control using Student's t test. 

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "*,"

Phrase: "p<0.05compared with unstimulated control"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Student's t test."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]
Processing 00000000.tx.126: ApoE Receptor, NMDA Receptor, and L-type Voltage-dependent Ca2+ Channel Are Involved in the Pathway-- To further elucidate the pathway where CREB is phosphorylated after apoE treatment, we examined the effects of RAP which is a competitive blocker of apoE for its receptor; 

Phrase: "ApoE Receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051300:ApoE Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "NMDA Receptor,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080093:NMDA receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1152805:NMDA receptor [Molecular Function]
   861   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "L-type Voltage-dependent Ca2+ Channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0439799:Channel [Spatial Concept]
   799   C1706095:Channel [Conceptual Entity]

Phrase: "Are"

Phrase: "Involved in the Pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1314939:Involved [Functional Concept]
   770   C1704259:Pathway [Molecular Function]
   770   C1705987:Pathway [Conceptual Entity]

Phrase: "--"

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "elucidate"

Phrase: "the pathway where CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   913   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   877   C3158668:cAMP response element binding [Genetic Function]
   845   C1148918:cAMP binding [Molecular Function]
   845   C1511573:cAMP Response Element [Gene or Genome]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0013879:Element [Element, Ion, or Isotope]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   795   C0243122:binding [Functional Concept]
   795   C0871261:Response [Organism Attribute]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1704632:Response [Finding]
   795   C1705248:Element [Conceptual Entity]
   795   C1706817:Response [Intellectual Product]
   795   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "phosphorylated after apoE treatment,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effects of RAP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "a competitive blocker of apoE"

Phrase: "for its receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.127: MK801 which is a selective antagonist of the NMDA receptor; 

Phrase: "MK801"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]

Phrase: "which"

Phrase: "is"

Phrase: "a selective antagonist of the NMDA receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0598695:NMDA receptor antagonist [Pharmacologic Substance]
   804   C3536824:NMDA Receptor Antagonist [Pharmacologic Substance]
   748   C0231491:Antagonist [Organ or Tissue Function]

Phrase: ";"
Processing 00000000.tx.128: and nifedipine which is a selective antagonist of the L-type voltage-dependent calcium channel (LVDCC). 

Phrase: "and"

Phrase: "nifedipine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028066:Nifedipine [Organic Chemical,Pharmacologic Substance]

Phrase: "which"

Phrase: "is"

Phrase: "a selective antagonist of the L-type voltage-dependent calcium channel (LVDCC)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0006684:calcium antagonist [Pharmacologic Substance]
   738   C0231491:Antagonist [Organ or Tissue Function]
Processing 00000000.tx.129: Pretreatment with RAP followed by apoE appeared to attenuate the increase in phospho-CREB levels seen with apoE treatment alone suggesting that the apoE receptor is involved in the pathway (Fig. 6A). 

Phrase: "Pretreatment with RAP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "followed by apoE"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0523511:APOE [Laboratory Procedure]
   790   C1412481:APOE [Gene or Genome]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "attenuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "the increase in phospho-CREB levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "seen with apoE treatment"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205397:Seen [Qualitative Concept]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the apoE receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051300:ApoE Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "involved in the pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1314939:Involved [Functional Concept]
   770   C1704259:Pathway [Molecular Function]
   770   C1705987:Pathway [Conceptual Entity]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.130: Similarly, pretreatment with MK801 or with nifedipine appeared to attenuate the increase in phospho-CREB levels, suggesting that the NMDA receptor and/or the LVDCC are also involved in the pathway (Fig. 6B). 

Phrase: "Similarly,"

Phrase: "pretreatment with MK801"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "or with nifedipine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0028066:Nifedipine [Organic Chemical,Pharmacologic Substance]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "attenuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "the increase in phospho-CREB levels,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the NMDA receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080093:NMDA receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1152805:NMDA receptor [Molecular Function]
   861   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and/or"

Phrase: "the LVDCC"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   913   C0288263:L-Type Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C3538943:L-type calcium channel [Molecular Function]
   827   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   799   C0006726:Calcium [Inorganic Chemical]
   799   C0439799:Channel [Spatial Concept]
   799   C0598352:Voltage [Quantitative Concept]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1701901:Dependent [Qualitative Concept]
   799   C1706095:Channel [Conceptual Entity]
   799   C2936886:Calcium [Pharmacologic Substance]
   799   C3244310:dependent [Functional Concept]

Phrase: "are"

Phrase: "also"

Phrase: "involved in the pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1314939:Involved [Functional Concept]
   770   C1704259:Pathway [Molecular Function]
   770   C1705987:Pathway [Conceptual Entity]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.131: View larger version (29K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.132: 6.  

Phrase: "6."
Processing 00000000.tx.133: Various agents inhibit apoE-peptide-induced increases in phospho-CREB levels. 

Phrase: "Various agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "apoE-peptide-induced increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442805:increases [Functional Concept]

Phrase: "in phospho-CREB levels."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   845   C1547597:Response level [Idea or Concept]
   795   C0441889:Levels [Qualitative Concept]
   785   C0428479:Protein level [Laboratory or Test Result]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C3158668:cAMP response element binding [Genetic Function]
Processing 00000000.tx.134: Rat hippocampal neurons at day 7of culture were treated with 2M apoE peptide for 30min in the presence or absence of 1M RAP(A), the presence or absence of 100M MK801 or 20M nifedipine (B), the presence or absence of 10M U0126 or 10M cAMP-dependent protein kinase inhibitor (C), and the presence or absence of 10M SB203580, 10M KN62 or 10M U0126 (D). 

Phrase: "Rat hippocampal neurons at day 7of culture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0027882:Neurons [Cell]

Phrase: "were"

Phrase: "treated with 2M apoE peptide"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0523511:APOE [Laboratory Procedure]
   760   C1412481:APOE [Gene or Genome]
   760   C1522326:Treated [Functional Concept]
   760   C3171718:2M [Quantitative Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "for 30min"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 1M RAP(A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: ")"

Phrase: ","

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 100M MK801"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "20M nifedipine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028066:Nifedipine [Organic Chemical,Pharmacologic Substance]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 10M U0126"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "10M cAMP-dependent protein kinase inhibitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   827   C3537023:kinase inhibitor [Molecular Function]
   827   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   799   C1999216:Inhibitor [Qualitative Concept]
   734   C0010531:cAMP-Dependent Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 10M SB203580,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "10M KN62"

Phrase: "or"

Phrase: "10M U0126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.135: Cell lysates (20g/lane) were electrophoresed on SDS-PAGE, Western blotted, and probed with anti-phospho-CREB antibody or anti-CREB antibody. 

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(20g/lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "electrophoresed on SDS-PAGE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0013855:electrophorese [Laboratory Procedure]

Phrase: "Western"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:Western [Spatial Concept]

Phrase: "blotted"

Phrase: ","

Phrase: "and"

Phrase: "probed with anti-phospho-CREB antibody"
Meta Candidates (Total=27; Excluded=1; Pruned=0; Remaining=26)
   833   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C3158668:cAMP response element binding [Genetic Function]
   782   C1511573:cAMP Response Element [Gene or Genome]
   760   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0003261:Antibody Response [Biologic Function]
   757 E C0033618:Protein Binding [Molecular Function]
   757   C1148918:cAMP binding [Molecular Function]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0013879:Element [Element, Ion, or Isotope]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   739   C0243122:binding [Functional Concept]
   739   C0871261:Response [Organism Attribute]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1704632:Response [Finding]
   739   C1705248:Element [Conceptual Entity]
   739   C1706817:Response [Intellectual Product]
   739   C2911692:Response [Mental Process]
   706   C0182400:Probe [Medical Device]
   706   C1704681:Probe [Gene or Genome]
   706   C2347609:Probe [Chemical Viewed Functionally]
   706   C3536729:Probe [Manufactured Object]

Phrase: "or"

Phrase: "anti-CREB antibody."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   893   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C3158668:cAMP response element binding [Genetic Function]
Processing 00000000.tx.136: The ratios of phosphorylated CREB to total CREB are plotted as a meanS.E. of at least four separate experiments. 

Phrase: "The ratios of phosphorylated CREB"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0456603:Ratios [Quantitative Concept]
   742   C1610540:*Ratios [Quantitative Concept]
   708 E C1547037:Ratio [Intellectual Product]

Phrase: "to total CREB"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   895   C0555903:Total protein [Laboratory Procedure]
   895   C1261360:total protein [Laboratory or Test Result]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "are"

Phrase: "plotted as a meanS.E. of"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C1704970:Means [Conceptual Entity]
   719 E C0444504:Mean [Quantitative Concept]
   719 E C2347634:Mean [Quantitative Concept]
   719 E C2348143:Mean [Quantitative Concept]

Phrase: "at least four separate experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.137: Significance of the difference between apoE-peptide alone (bar labeled a) and treatment conditions were calculated with Student's t test where double asterisks represent p<0.05(A-D). 

Phrase: "Significance of the difference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "between apoE-peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "a)"

Phrase: "and"

Phrase: "treatment conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "calculated with Student's t test where"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0022885:Test [Laboratory Procedure]
   753   C0038492:student [Professional or Occupational Group]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C0444686:Calculated [Functional Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C1551041:student [Idea or Concept]
   753   C1552573:student [Intellectual Product]

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "asterisks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisks [Conceptual Entity]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "p<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "(A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "D)."
Processing 00000000.tx.138: Activation of MEK and Protein Kinase A Is Involved in the Pathway-- To find out which of the possible pathways involving apoE receptors, LVDCC and/or NMDA receptors, contribute to the phosphorylation of CREB, we examined the effect of inhibiting kinases associated with these receptors by treatment with the U0126 inhibitor of MAPK/ERK kinase (MEK) and with the c-AMP-dependent protein kinase inhibitor of protein kinase A (PKA). 

Phrase: "Activation of MEK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1155551:MAPK activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "Protein Kinase A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Is"

Phrase: "Involved in the Pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1314939:Involved [Functional Concept]
   770   C1704259:Pathway [Molecular Function]
   770   C1705987:Pathway [Conceptual Entity]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "which of the possible pathways"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0332149:Possible [Qualitative Concept]
   760   C1704259:Pathways [Molecular Function]
   760   C1705910:Possible [Qualitative Concept]
   760   C1705987:Pathways [Conceptual Entity]
   760   C2362652:Possible [Qualitative Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "apoE receptors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0051300:ApoE Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "LVDCC"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   913   C0288263:L-Type Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C3538943:L-type calcium channel [Molecular Function]
   827   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   799   C0006726:Calcium [Inorganic Chemical]
   799   C0439799:Channel [Spatial Concept]
   799   C0598352:Voltage [Quantitative Concept]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1701901:Dependent [Qualitative Concept]
   799   C1706095:Channel [Conceptual Entity]
   799   C2936886:Calcium [Pharmacologic Substance]
   799   C3244310:dependent [Functional Concept]

Phrase: "and/or"

Phrase: "NMDA receptors,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0080093:NMDA Receptors [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1152805:NMDA receptor [Molecular Function]
   861   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "contribute to the phosphorylation of CREB,"
Meta Candidates (Total=23; Excluded=1; Pruned=0; Remaining=22)
   833   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C3158668:cAMP response element binding [Genetic Function]
   782   C1511573:cAMP Response Element [Gene or Genome]
   775   C1657589:response to cAMP [Cell Function]
   760   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   757 E C0033618:Protein Binding [Molecular Function]
   757   C1148918:cAMP binding [Molecular Function]
   757   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   739   C0013879:Element [Element, Ion, or Isotope]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   739   C0243122:binding [Functional Concept]
   739   C0871261:Response [Organism Attribute]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1704632:Response [Finding]
   739   C1705248:Element [Conceptual Entity]
   739   C1706817:Response [Intellectual Product]
   739   C1880177:Contribute [Activity]
   739   C2911692:Response [Mental Process]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of inhibiting kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "associated with these receptors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "by treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with the U0126 inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "of MAPK/ERK kinase (MEK)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   713   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   713   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and with the c-AMP-dependent protein kinase inhibitor"
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   804   C1514555:Protein Kinase C Inhibitor [Pharmacologic Substance]
   790   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   784   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   781   C0072348:Protein C Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   781   C1418370:PROTEIN C INHIBITOR [Gene or Genome]
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   764   C3537023:kinase inhibitor [Molecular Function]
   764   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   762   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C1168438:Protein C [Laboratory Procedure]
   762   C1418943:PROTEIN C [Gene or Genome]
   762   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0851827:Dependent [Qualitative Concept]
   742   C1515981:And [Idea or Concept]
   742   C1701901:Dependent [Qualitative Concept]
   742   C1999216:Inhibitor [Qualitative Concept]
   742   C3244310:dependent [Functional Concept]

Phrase: "of protein kinase A (PKA)."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.139: Pretreatment with one of these selective inhibitors, as well as pretreatment with both, mostly inhibited CREB phosphorylation suggesting that activation of MEK and PKA are involved in this pathway (Fig. 6C). 

Phrase: "Pretreatment with one of these selective inhibitors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1550147:Pretreatment [Substance]
   748   C2709094:pre treatment [Temporal Concept]
   748   C3539075:Pretreatment [Temporal Concept]
   748   C3539076:Pretreatment [Activity]

Phrase: "as well as"

Phrase: "pretreatment with both,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "mostly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750554:mostly [Idea or Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "CREB phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   799   C0031715:Phosphorylation [Molecular Function]
   780   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C3158668:cAMP response element binding [Genetic Function]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that activation of MEK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1155551:MAPK activation [Molecular Function]
   753   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "PKA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "involved in this pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1314939:Involved [Functional Concept]
   770   C1704259:Pathway [Molecular Function]
   770   C1705987:Pathway [Conceptual Entity]

Phrase: "(Fig. 6C"

Phrase: ")."
Processing 00000000.tx.140: ERK Cascade Is a Major Pathway Leading to the ApoE Peptide-stimulated Phosphorylation of CREB-- To further investigate the apoE stimulation pathway, we examined the effect of inhibiting kinases associated with the receptor signaling by treatment with the SB203580 inhibitor of p38 MAP kinase, KN62 inhibitor of calmodulin-dependent protein kinases (CaMK II/IV), and the U0126 inhibitor of MEK. 

Phrase: "ERK Cascade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1707310:Cascade [Manufactured Object]
   750   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   750   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Is"

Phrase: "a Major Pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "Leading to the ApoE Peptide-stimulated Phosphorylation"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0332152:Leading [Temporal Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1158886:Phosphorylation [Molecular Function]
   748   C1412481:APOE [Gene or Genome]
   748   C1522538:Leading [Functional Concept]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "of CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "--"

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the apoE stimulation pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of inhibiting kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "associated with the receptor signaling"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1514762:Receptor Signaling [Molecular Function]
   760   C0037083:Signaling [Cell Function]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C3537152:signaling [Biologic Function]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "by treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with the SB203580 inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "of p38 MAP kinase,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0257535:p38 map kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1120843:p38 MAP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0024779:Map [Manufactured Object]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1706473:Map [Conceptual Entity]

Phrase: "KN62 inhibitor of calmodulin-dependent protein kinases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   788   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   757   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   757   C3537023:kinase inhibitor [Molecular Function]
   757   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(CaMK II/IV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C3541431:CAMK-II [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the U0126 inhibitor of MEK."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C2347168:MAPK/ERK Kinase Inhibitor [Pharmacologic Substance]
   774   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   774   C3537023:kinase inhibitor [Molecular Function]
   774   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.141: Of these selective inhibitors, CREB phosphorylation was mostly inhibited by pretreatment with U0126 while pretreatment with KN62 or SB203580 did not appear to have any significant effect on the phosphorylation status of CREB. 

Phrase: "Of these selective inhibitors,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "CREB phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   799   C0031715:Phosphorylation [Molecular Function]
   780   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C3158668:cAMP response element binding [Genetic Function]

Phrase: "was"

Phrase: "mostly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750554:mostly [Idea or Concept]

Phrase: "inhibited by pretreatment"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0311403:Inhibited [Qualitative Concept]
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "with U0126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "while"

Phrase: "pretreatment with KN62"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "or"

Phrase: "SB203580"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0297666:SB203580 [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "any significant effect on the phosphorylation status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "of CREB."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]
Processing 00000000.tx.142: This result suggests that the ERK cascade is a major pathway leading to the apoE-stimulated phosphorylation of CREB (Fig. 6D). 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the ERK cascade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1707310:Cascade [Manufactured Object]
   750   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   750   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a major pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "leading to the apoE-stimulated phosphorylation"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0332152:Leading [Temporal Concept]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1412481:APOE [Gene or Genome]
   753   C1522538:Leading [Functional Concept]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "of CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "(Fig. 6D"

Phrase: ")."
Processing 00000000.tx.143: Elevation of Intracellular Ca2+ following ApoE Peptide Treatment Involves the ApoE Receptor, NMDA Receptor, and L-type Voltage-dependent Ca2+ Channel-- To demonstrate if the elevation of intracellular Ca2+ parallels the phosphorylation of CREB, we measured the concentration of intracellular Ca2+ under unstimulated or apoE peptide-stimulated conditions. 

Phrase: "Elevation of Intracellular Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439775:Elevation [Therapeutic or Preventive Procedure]
   770   C0702240:Elevation [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "ApoE Peptide Treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "Involves"

Phrase: "the ApoE Receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051300:ApoE Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "NMDA Receptor,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080093:NMDA receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1152805:NMDA receptor [Molecular Function]
   861   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "L-type Voltage-dependent Ca2+ Channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0439799:Channel [Spatial Concept]
   799   C1706095:Channel [Conceptual Entity]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "if"

Phrase: "the elevation of intracellular Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439775:Elevation [Therapeutic or Preventive Procedure]
   760   C0702240:Elevation [Spatial Concept]

Phrase: "parallels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348042:Parallel [Qualitative Concept]
  1000   C2826345:PARALLEL [Research Activity]

Phrase: "the phosphorylation of CREB,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   744   C0031715:Phosphorylation [Molecular Function]
   703   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the concentration of intracellular Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "under unstimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439819:Unstimulated [Qualitative Concept]

Phrase: "or"

Phrase: "apoE peptide-stimulated conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.144: Treatment with apoE peptide significantly raised the concentration of intracellular calcium in rat hippocampal neurons. 

Phrase: "Treatment with apoE peptide significantly"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "raised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442818:Raised [Quantitative Concept]

Phrase: "the concentration of intracellular calcium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "in rat hippocampal neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.145: Preincubation with RAP, MK801, or nifedipine significantly attenuated this elevation, suggesting that the apoE receptor, NMDA receptor, and LVDCC are involved in the pathway to calcium elevation as was observed for the activation of CREB (Fig. 7A). 

Phrase: "Preincubation with RAP,"

Phrase: "MK801,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "nifedipine significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028066:Nifedipine [Organic Chemical,Pharmacologic Substance]

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "this elevation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439775:Elevation [Therapeutic or Preventive Procedure]
  1000   C0702240:Elevation [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the apoE receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051300:ApoE Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "NMDA receptor,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080093:NMDA receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1152805:NMDA receptor [Molecular Function]
   861   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "LVDCC"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   913   C0288263:L-Type Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C3538943:L-type calcium channel [Molecular Function]
   827   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   799   C0006726:Calcium [Inorganic Chemical]
   799   C0439799:Channel [Spatial Concept]
   799   C0598352:Voltage [Quantitative Concept]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1701901:Dependent [Qualitative Concept]
   799   C1706095:Channel [Conceptual Entity]
   799   C2936886:Calcium [Pharmacologic Substance]
   799   C3244310:dependent [Functional Concept]

Phrase: "are"

Phrase: "involved in the pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1314939:Involved [Functional Concept]
   770   C1704259:Pathway [Molecular Function]
   770   C1705987:Pathway [Conceptual Entity]

Phrase: "to calcium elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439775:Elevation [Therapeutic or Preventive Procedure]
   861   C0702240:Elevation [Spatial Concept]

Phrase: "as"

Phrase: "was"

Phrase: "observed for the activation of CREB"
Meta Candidates (Total=23; Excluded=1; Pruned=0; Remaining=22)
   833   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C3158668:cAMP response element binding [Genetic Function]
   795   C2245434:activation of protein binding [Molecular Function]
   782   C1511573:cAMP Response Element [Gene or Genome]
   777   C2259194:activation of binding [Molecular Function]
   760   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   757 E C0033618:Protein Binding [Molecular Function]
   757   C0599177:protein activation [Genetic Function]
   757   C1148918:cAMP binding [Molecular Function]
   739   C0013879:Element [Element, Ion, or Isotope]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   739   C0243122:binding [Functional Concept]
   739   C0871261:Response [Organism Attribute]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1441672:Observed [Functional Concept]
   739   C1704632:Response [Finding]
   739   C1705248:Element [Conceptual Entity]
   739   C1706817:Response [Intellectual Product]
   739   C1879547:Activation [Activity]
   739   C2911692:Response [Mental Process]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.146: View larger version (23K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.147: 7.  

Phrase: "7."
Processing 00000000.tx.148: Intracellular calcium levels increase after apoE-peptide treatment. 

Phrase: "Intracellular calcium levels"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   901   C0201925:calcium levels [Laboratory Procedure]
   901   C0428302:calcium levels [Laboratory or Test Result]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0175996:intracellular [Cell Component]
   827   C0178719:Intracellular [Spatial Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C2936886:Calcium [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "increase after apoE-peptide treatment."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0442805:Increase [Functional Concept]
   760   C0523511:APOE [Laboratory Procedure]
   760   C1412481:APOE [Gene or Genome]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
   704 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.149: As a measure of intracellular calcium levels, Fura 2fluorescence in 7-day-old rat hippocampal neuronal cultures increases rapidly after treatment with apoE-peptide (bar labeled a). 

Phrase: "As a measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "of intracellular calcium levels,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   901   C0201925:calcium levels [Laboratory Procedure]
   901   C0428302:calcium levels [Laboratory or Test Result]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0175996:intracellular [Cell Component]
   827   C0178719:Intracellular [Spatial Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C2936886:Calcium [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "Fura 2fluorescence in 7-day-old rat hippocampal neuronal cultures"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "after"

Phrase: "treatment with apoE-peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "(bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "a"

Phrase: ")."
Processing 00000000.tx.150: This apoE-peptide stimulated fluorescence is inhibited by pretreatment with RAP, MK801 at 10or 100M, or nifedipine at 10or 100M. 

Phrase: "This apoE-peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "is"

Phrase: "inhibited by pretreatment"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0311403:Inhibited [Qualitative Concept]
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "with RAP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416920:RAP [Gene or Genome]

Phrase: "MK801 at 10or 100M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "nifedipine at 10or 100M."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0028066:Nifedipine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.151: Peak values of intracellular calcium were observed about 40s after exposure to apoE-peptide in at least 10neurons per experiment in each of four separate experiments. 

Phrase: "Peak values of intracellular calcium"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "observed about 40s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "after exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to apoE-peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "in"

Phrase: "at least 10neurons"

Phrase: "per experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "in each"

Phrase: "of four separate experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.152: Compared with the apoE-peptide alone, significant inhibition of calcium fluorescence at the p<0.01are calculated with a Student's t test and marked by a double asterisk (A). 

Phrase: "Compared with the apoE-peptide alone, significant inhibition of calcium fluorescence"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   738   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   738   C0006726:Calcium [Inorganic Chemical]
   738   C0016315:Fluorescence [Natural Phenomenon or Process]
   738   C0021467:Inhibition [Mental Process]
   738   C0021469:Inhibition [Molecular Function]
   738   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   738   C0205171:Alone [Quantitative Concept]
   738   C0237881:significant [Quantitative Concept]
   738   C0439044:alone [Finding]
   738   C0523511:APOE [Laboratory Procedure]
   738   C0679994:alone [Group Attribute]
   738   C0750502:Significant [Idea or Concept]
   738   C1412481:APOE [Gene or Genome]
   738   C1546944:Significant [Qualitative Concept]
   738   C1628982:% inhibition [Quantitative Concept]
   738   C1707455:Compared [Activity]
   738   C2936886:Calcium [Pharmacologic Substance]
   738   C3463820:Inhibition [Activity]

Phrase: "at the p<0.01are"

Phrase: "calculated with a Student's t test"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0022885:Test [Laboratory Procedure]
   753   C0038492:student [Professional or Occupational Group]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C0444686:Calculated [Functional Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C1551041:student [Idea or Concept]
   753   C1552573:student [Intellectual Product]

Phrase: "and"

Phrase: "marked by a double asterisk"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205173:Double [Functional Concept]
   760   C0522501:Marked [Qualitative Concept]
   760   C1705764:Double [Activity]
   760   C1705765:Double [Qualitative Concept]
   760   C1706089:Marked [Qualitative Concept]
   760   C2945706:asterisk [Conceptual Entity]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.153: ApoE-peptide induces a rapid elevation of intracellular calcium fluorescence in rat hippocampal neurons (bar a) that is inhibited by culturing in Ca2+-free growth medium or in the presence of growth medium containing calcium and 10M dantrolene. 

Phrase: "ApoE-peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a rapid elevation of intracellular calcium fluorescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439775:Elevation [Therapeutic or Preventive Procedure]
   748   C0702240:Elevation [Spatial Concept]

Phrase: "in rat hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "("

Phrase: "bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "a)"

Phrase: "that"

Phrase: "is"

Phrase: "inhibited by culturing"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0311403:Inhibited [Qualitative Concept]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "in Ca2+-free growth medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   812   C0009458:Medium [Intellectual Product]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0439536:Medium [Quantitative Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1705217:Medium [Substance]
   812   C2911660:Growth [Activity]
   812   C3244283:medium [Intellectual Product]

Phrase: "or in the presence of growth medium containing calcium"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   764   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   742   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0006726:Calcium [Inorganic Chemical]
   742   C0009458:Medium [Intellectual Product]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0220844:growth [Physiologic Function]
   742   C0332256:Containing [Functional Concept]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0439536:Medium [Quantitative Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1705217:Medium [Substance]
   742   C2700400:Containing [Activity]
   742   C2911660:Growth [Activity]
   742   C2936886:Calcium [Pharmacologic Substance]
   742   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "10M dantrolene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010976:Dantrolene [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.154: Peak concentrations of intracellular calcium in at least 10neurons for each of four experiments are plotted. 

Phrase: "Peak concentrations of intracellular calcium"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C2347813:Peak Concentration [Quantitative Concept]
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "in"

Phrase: "at least 10neurons"

Phrase: "for each"

Phrase: "of four experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "are"

Phrase: "plotted."
Processing 00000000.tx.155: Significance of the difference between apoE-peptide alone and treatment conditions were calculated with Student's t test where double asterisks represent p<0.01(B). 

Phrase: "Significance of the difference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "between apoE-peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "and"

Phrase: "treatment conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "calculated with Student's t test where"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0022885:Test [Laboratory Procedure]
   753   C0038492:student [Professional or Occupational Group]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C0444686:Calculated [Functional Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C1551041:student [Idea or Concept]
   753   C1552573:student [Intellectual Product]

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "asterisks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisks [Conceptual Entity]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "p<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.156: A Major Part of the Intracellular Ca2+ Elevation May Be from an Intracellular Source-- To determine whether calcium influx from the extracellular space or from the endoplasmic reticulum (ER) contributes to our apoE-mediated Ca2+ increases, we measured the intracellular Ca2+ elevation in rat primary hippocampal neurons cultured in medium lacking Ca2+ and containing 1mM EGTA (Fig. 7B). 

Phrase: "A Major Part of the Intracellular Ca2+ Elevation May"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1292711:Part of [Spatial Concept]
   762   C1820033:intracellular part [Cell Component]
   742   C0449719:Part [Spatial Concept]
   742   C1709471:Part [Quantitative Concept]

Phrase: "Be from an Intracellular Source"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]
   760   C2987476:Be [Conceptual Entity]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "calcium influx from the extracellular space"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   820   C3158761:extracellular calcium influx [Cell Function]

Phrase: "or from the endoplasmic reticulum (ER)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]

Phrase: "contributes to our apoE-mediated Ca2+ increases,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0442805:increases [Functional Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1412481:APOE [Gene or Genome]
   748   C1880177:Contribute [Activity]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the intracellular Ca2+ elevation in rat primary hippocampal neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0439775:Elevation [Therapeutic or Preventive Procedure]
   742   C0702240:Elevation [Spatial Concept]

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "in medium lacking Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "containing 1mM EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.157: Under these conditions, apoE-stimulated calcium elevation was significantly attenuated suggesting that calcium influx from extracellular sources significantly contributes to the elevation of intracellular Ca2+. 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "apoE-stimulated calcium elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439775:Elevation [Therapeutic or Preventive Procedure]
   812   C0702240:Elevation [Spatial Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that calcium influx from extracellular sources significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3158761:extracellular calcium influx [Cell Function]

Phrase: "contributes to the elevation of intracellular Ca2+."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0175996:intracellular [Cell Component]
   748   C0178719:Intracellular [Spatial Concept]
   748   C0439775:Elevation [Therapeutic or Preventive Procedure]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0702240:Elevation [Spatial Concept]
   748   C1880177:Contribute [Activity]
Processing 00000000.tx.158: To confirm this finding, we also measured the contribution of calcium release from the endoplasmic reticulum to the increase in intracellular Ca2+. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "this finding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "we also"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the contribution of calcium release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "from the endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "to the increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "in intracellular Ca2+."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.159: Rat primary hippocampal neurons were preincubated with 10M dantrolene, an inhibitor of ryanodine-sensitive Ca2+ channel found on the ER membrane, followed by apoE peptide treatment. 

Phrase: "Rat primary hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "preincubated with 10M dantrolene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010976:Dantrolene [Organic Chemical,Pharmacologic Substance]
   770   C1442446:10M [Temporal Concept]

Phrase: "an inhibitor of ryanodine-sensitive Ca2+ channel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "found on the ER membrane,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0230770:endoplasmic reticulum membrane [Cell Component]
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   753   C0150312:Found [Quantitative Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   719 E C0243095:Find [Finding]

Phrase: "followed by apoE peptide treatment."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0523511:APOE [Laboratory Procedure]
   760   C1412481:APOE [Gene or Genome]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.160: Interestingly, preincubation with dantrolene also significantly attenuated the elevation of intracellular Ca2+. 

Phrase: "Interestingly,"

Phrase: "preincubation with dantrolene also significantly"

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "the elevation of intracellular Ca2+."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439775:Elevation [Therapeutic or Preventive Procedure]
   760   C0702240:Elevation [Spatial Concept]
Processing 00000000.tx.161: Combining extracellular Ca2+-free conditions and preincubation with dantrolene also attenuated the calcium elevation, even though there was no significant difference between the calcium levels measured under extracellular Ca2+-free conditions without dantrolene preincubation and the extracellular calcium-free condition with dantrolene preincubation. 

Phrase: "Combining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0336789:Combine [Manufactured Object]

Phrase: "extracellular Ca2+-free conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and"

Phrase: "preincubation with dantrolene also"

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "the calcium elevation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439775:Elevation [Therapeutic or Preventive Procedure]
   861   C0702240:Elevation [Spatial Concept]

Phrase: "even"

Phrase: "though"

Phrase: "there"

Phrase: "was"

Phrase: "no significant difference between the calcium levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "measured under extracellular Ca2+-free conditions"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   753   C0332296:free [Functional Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C0521119:Extracellular [Cell Component]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719   C0012634:condition [Disease or Syndrome]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]

Phrase: "without dantrolene preincubation"

Phrase: "and"

Phrase: "the extracellular calcium-free condition with dantrolene preincubation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0012634:condition [Disease or Syndrome]
   744   C0348080:Condition [Qualitative Concept]
   744   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.162: Taken together, we hypothesize that the calcium influx from extracellular sources triggers the release of Ca2+ from intracellular endoplasmic reticulum sources through its ryanodine-sensitive Ca2+ channels. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "we"

Phrase: "hypothesize"

Phrase: "that"

Phrase: "the calcium influx from extracellular sources"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   820   C3158761:extracellular calcium influx [Cell Function]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "the release of Ca2+"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from intracellular endoplasmic reticulum sources"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0449416:sources [Finding]
   779 E C1705919:Source [Idea or Concept]

Phrase: "through its ryanodine-sensitive Ca2+ channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.163: Calcium influx from extracellular space seems to be essential for signaling the apoE-stimulated elevation of intracellular Ca2+ levels, but contributes only a small amount to the rise in intracellular calcium levels compared with the calcium released from the ER.  

Phrase: "Calcium influx from extracellular space"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   844   C3158761:extracellular calcium influx [Cell Function]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "essential for signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205224:Essential [Qualitative Concept]

Phrase: "the apoE-stimulated elevation of intracellular Ca2+ levels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439775:Elevation [Therapeutic or Preventive Procedure]
   744   C0702240:Elevation [Spatial Concept]

Phrase: "but"

Phrase: "contributes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a small amount to the rise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "in intracellular calcium levels"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   901   C0201925:calcium levels [Laboratory Procedure]
   901   C0428302:calcium levels [Laboratory or Test Result]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0175996:intracellular [Cell Component]
   827   C0178719:Intracellular [Spatial Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C2936886:Calcium [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "compared with the calcium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0006726:Calcium [Inorganic Chemical]
   770   C1707455:Compared [Activity]
   770   C2936886:Calcium [Pharmacologic Substance]

Phrase: "released from the ER."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0391871:Released [Functional Concept]
   760   C1283071:Released [Functional Concept]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.164: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Although evidence of the association between the 4 allele of the APOE gene and Alzheimer's disease is overwhelming, the mechanism by which the apoE4 protein isoform influences onset and progression of the disease and its pathology is unknown. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   758   C1514811:Reference [Idea or Concept]
   758   C1706462:Reference [Conceptual Entity]

Phrase: "Although"

Phrase: "evidence of the association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "between the 4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "of the APOE gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1412481:Apolipoprotein E gene [Gene or Genome]
   913   C1445865:Apolipoprotein gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "overwhelming,"

Phrase: "the mechanism by which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "the apoE4 protein isoform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0597298:protein isoform [Amino Acid, Peptide, or Protein]
           Isoform

Phrase: "influences"

Phrase: "onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "progression of the disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0242656:Disease Progression [Pathologic Function]
           progression
   819   C1947900:Disease progression NOS [Finding]
   770   C0449258:Progression [Functional Concept]

Phrase: "and"

Phrase: "its pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.165: Of the many suggested mechanisms, we have focused on reports that apoE3 and apoE4 protein isoforms have differential effects on neuronal plasticity and survival (13, 23, 24). 

Phrase: "Of the"

Phrase: "many suggested mechanisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "we"

Phrase: "have"

Phrase: "focused on"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0205234:Focused [Spatial Concept]
   833   C1285542:focused [Functional Concept]

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "apoE4 protein isoforms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms

Phrase: "have"

Phrase: "differential effects on neuronal plasticity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "(13,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.166: Compared with the apoE3 protein isoform, apoE4 protein, proteolytic fragments of apoE4 protein, and peptides corresponding to the receptor-binding domain of apoE proteins appear to actively injure, and certainly do not support maintenance of healthy neurites and neuronal cells (13-16). 

Phrase: "Compared with the apoE3 protein isoform,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0597298:protein isoform [Amino Acid, Peptide, or Protein]
           Isoform
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]
   753   C1707455:Compared [Activity]

Phrase: "apoE4 protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "proteolytic fragments of apoE4 protein,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   781   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0332255:fragments [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   726 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "corresponding to the receptor-binding domain of apoE proteins"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   773   C1514535:Protein Binding Domain [Amino Acid Sequence]
   764   C0597358:Receptor Binding [Molecular Function]
   762   C0051300:ApoE Receptor [Amino Acid, Peptide, or Protein,Receptor]
   762   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0597357:proteins receptor [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   745 E C0033618:Protein Binding [Molecular Function]
   745   C0162808:Protein Domain [Spatial Concept]
   745   C1514562:Protein Domain [Amino Acid Sequence]
   742   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0243122:binding [Functional Concept]
   742   C0523511:APOE [Laboratory Procedure]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1412481:APOE [Gene or Genome]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to actively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "injure"

Phrase: ","

Phrase: "and"

Phrase: "certainly"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "maintenance of healthy neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0262500:Health maintenance [Health Care Activity]
   770   C0024501:Maintenance [Activity]

Phrase: "and"

Phrase: "neuronal cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(13-16"

Phrase: ")."
Processing 00000000.tx.167: On the larger scale, the failure of apoE4 protein isoforms and their related fragments to support neuronal plasticity and maintenance may infer a mechanism that underlies the association between APOE gene alleles and disease. 

Phrase: "On the larger scale,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0175659:Scale [Medical Device]
   861   C0349674:Scale [Intellectual Product]
   861   C1947916:Scale [Activity]
   861   C3536777:Scale [Manufactured Object]
   789 E C1710017:Scalar [Qualitative Concept]
   777 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: "the failure of apoE4 protein isoforms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0231174:Failure [Functional Concept]
   753   C0680095:failure [Individual Behavior]

Phrase: "and"

Phrase: "their related fragments to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "neuronal plasticity"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0027880:Neuronal Plasticity [Organ or Tissue Function]
   861   C0521390:Neuronal [Immunologic Factor]
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0027882:Neuron [Cell]
   789 E C0032167:Plastic [Substance]

Phrase: "and"

Phrase: "maintenance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintenance [Activity]

Phrase: "may"

Phrase: "infer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679201:Infer [Mental Process]

Phrase: "a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "underlies"

Phrase: "the association between APOE gene alleles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.168: Under many conditions that eventually result in neuronal death, the cell struggles to induce protective mechanisms even though destructive forces inevitably march forward. 

Phrase: "Under many conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "that eventually"

Phrase: "result in neuronal death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C2754100:neuron death [Cell Function]
   770   C0011065:Death [Organism Function]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1274040:Result [Functional Concept]
   770   C1306577:Death, NOS [Finding]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "the cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "struggles"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "protective mechanisms even"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "though"

Phrase: "destructive forces inevitably march"

Phrase: "forward."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]
Processing 00000000.tx.169: In this report, we have demonstrated one such scenario where apoE4, but not apoE3, activates an ERK cascade that results in activation of CREB and induction of many different genes including the cell-protective gene, Bcl-2. 

Phrase: "In this report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "such scenario where apoE4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   827   C2984964:APOE4 [Laboratory Procedure]

Phrase: "but"

Phrase: "not apoE3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "an ERK"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   979   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   979   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0521119:Extracellular [Cell Component]
   812   C0851285:Regulated [Governmental or Regulatory Activity]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "cascade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707310:Cascade [Manufactured Object]

Phrase: "that results in activation of CREB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706   C2825142:Result [Finding]

Phrase: "and"

Phrase: "induction of many different genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0920532:gene induction [Genetic Function]
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the cell-protective gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1861886:CELL Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "Bcl-2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]
Processing 00000000.tx.170: In prior reports, we showed that overexpression of only Bcl-2 protein could inhibit neuronal death following a toxic insult (25). 

Phrase: "In prior reports,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that overexpression of only Bcl-2 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "could"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "neuronal death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C2754100:neuron death [Cell Function]
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a toxic insult"

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.171: In this case, treatment of neurons with recombinant apoE4 protein or with synthetic apoE peptide resulted in CREB phosphorylation and induced Bcl-2 expression, events which were not observed following recombinant apoE3 protein treatments. 

Phrase: "In this case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "treatment of neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with recombinant apoE4 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or with synthetic apoE peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0523511:APOE [Laboratory Procedure]
   760   C1412481:APOE [Gene or Genome]
   760   C1883254:synthetic [Activity]

Phrase: "resulted in CREB phosphorylation"
Meta Candidates (Total=24; Excluded=1; Pruned=0; Remaining=23)
   869   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C3158668:cAMP response element binding [Genetic Function]
   800   C1511573:cAMP Response Element [Gene or Genome]
   770   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   767 E C0033618:Protein Binding [Molecular Function]
   767   C1148918:cAMP binding [Molecular Function]
   744   C0013879:Element [Element, Ion, or Isotope]
   744   C0031715:Phosphorylation [Molecular Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   744   C0243122:binding [Functional Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1704632:Response [Finding]
   744   C1705248:Element [Conceptual Entity]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "and"

Phrase: "induced Bcl-2 expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441471:Events [Event]
  1000   C3541888:Events [Classification]

Phrase: "which"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "recombinant apoE3 protein treatments."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   812   C0087111:Treatments [Therapeutic or Preventive Procedure]
   779 E C0039798:treatment [Functional Concept]
   779 E C1522326:Treatment [Functional Concept]
   779 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   779 E C1705169:Treatment [Conceptual Entity]
   779 E C3538994:TREATMENT [Research Activity]
   708   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.172: Time course experiments showed that the increase in phospho-CREB levels following apoE4 protein treatments appeared to be slower than that by apoE peptide, although their molar concentrations were the same. 

Phrase: "Time course experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0449247:Time course [Temporal Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the increase in phospho-CREB levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "apoE4 protein treatments"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0087111:Treatments [Therapeutic or Preventive Procedure]
   793 E C0039798:treatment [Functional Concept]
   793 E C1522326:Treatment [Functional Concept]
   793 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   793 E C1705169:Treatment [Conceptual Entity]
   793 E C3538994:TREATMENT [Research Activity]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "slower than that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0439834:Slow [Qualitative Concept]

Phrase: "by apoE peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "although"

Phrase: "their molar concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0026367:Molar [Body Part, Organ, or Organ Component]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "the same."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]
Processing 00000000.tx.173: This time lag is consistent with previous results where protease inhibitors reduced the neurotoxicity of apoE4 (16) through a presumed mechanism where the full-length apoE4 protein must be digested over time to produce a toxic fragment of apoE4. 

Phrase: "This time lag"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416797:Lag [Gene or Genome]

Phrase: "is"

Phrase: "consistent with previous results where protease inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the neurotoxicity of apoE4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "(16"

Phrase: ")"

Phrase: "through a presumed mechanism where"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "the full-length apoE4 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "must"

Phrase: "be"

Phrase: "digested over time to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0040223:Time [Temporal Concept]
   770   C0868946:digested [Physiologic Function]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "produce"

Phrase: "a toxic fragment of apoE4."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332255:fragment [Functional Concept]
   760   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.174: Despite the increases in phospho-CREB and Bcl-2, we also observed apoE4/apoE peptide-mediated increases in calcium levels that were also observed by others in the context of their association with neuronal death (16, 26). 

Phrase: "Despite the increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]

Phrase: "in phospho-CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   947   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:cAMP response element binding [Genetic Function]
   861   C1511573:cAMP Response Element [Gene or Genome]
   858   C1148918:cAMP binding [Molecular Function]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0243122:binding [Functional Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "Bcl-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "we also observed apoE4/apoE peptide-mediated increases in calcium levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0442805:increases [Functional Concept]

Phrase: "that"

Phrase: "were"

Phrase: "also"

Phrase: "observed by others"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1441672:Observed [Functional Concept]
   790   C1955473:Others [Finding]

Phrase: "in the context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "of their association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with neuronal death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C2754100:neuron death [Cell Function]
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]

Phrase: "(16,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.175: The apoE4/apoE-peptide-mediated increase of intracellular Ca2+ can be generated by calcium influx from the extracellular space and release of calcium from intracellular stores. 

Phrase: "The apoE4/apoE-peptide-mediated increase of intracellular Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "generated by calcium influx"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0006726:Calcium [Inorganic Chemical]
   770   C2936886:Calcium [Pharmacologic Substance]
   770   C3146294:Generated [Activity]

Phrase: "from the extracellular space"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015352:Extracellular Space [Body Space or Junction]
   861   C1883067:Space [Spatial Concept]

Phrase: "and"

Phrase: "release of calcium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0030685:Release [Health Care Activity]
   790   C0391871:Release [Functional Concept]
   790   C0439180:% release [Quantitative Concept]
   790   C0680255:release [Health Care Activity]
   790   C1283071:Release [Functional Concept]
   790   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from intracellular stores."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1698986:Store [Functional Concept]
Processing 00000000.tx.176: Significant attenuation of increased intracellular calcium levels was observed when we cultured rat primary hippocampal neurons in the medium lacking Ca2+ and containing EGTA as a Ca2+ chelator, suggesting that calcium influx from extracellular sources follows apoE4/apoE peptide treatments. 

Phrase: "Significant attenuation of increased intracellular calcium levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0599946:Attenuation [Activity]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "we"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "rat primary hippocampal neurons in the medium lacking Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0027882:Neurons [Cell]

Phrase: "and"

Phrase: "containing EGTA as a Ca2+ chelator,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that calcium influx from extracellular sources"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   820   C3158761:extracellular calcium influx [Cell Function]

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "apoE4/apoE peptide treatments."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0087111:Treatments [Therapeutic or Preventive Procedure]
   779 E C0039798:treatment [Functional Concept]
   779 E C1522326:Treatment [Functional Concept]
   779 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   779 E C1705169:Treatment [Conceptual Entity]
   779 E C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.177: When we measured the intracellular Ca2+ elevation following preincubation with 10M dantrolene, an inhibitor of ryanodine-sensitive Ca2+ channel on ER membranes, Ca2+ elevation was also significantly attenuated, suggesting the participation of the calcium influx from ER in the elevation of intracellular Ca2+. 

Phrase: "When"

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the intracellular Ca2+ elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439775:Elevation [Therapeutic or Preventive Procedure]
   827   C0702240:Elevation [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "preincubation with 10M dantrolene,"

Phrase: "an inhibitor of ryanodine-sensitive Ca2+ channel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "on ER membranes,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0230770:endoplasmic reticulum membrane [Cell Component]
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "Ca2+ elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439775:Elevation [Therapeutic or Preventive Procedure]
   861   C0702240:Elevation [Spatial Concept]

Phrase: "was"

Phrase: "also significantly"

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the participation of the calcium influx"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679823:Participation [Functional Concept]

Phrase: "from ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "in the elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439775:Elevation [Therapeutic or Preventive Procedure]
  1000   C0702240:Elevation [Spatial Concept]

Phrase: "of intracellular Ca2+."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.178: Interestingly, extracellular Ca2+-free conditions did not seem to have any additional effect on attenuating the Ca2+ elevation following preincubation with dantrolene, suggesting that calcium influx from the extracellular space may serve to trigger a larger amount of Ca2+ release from the ER through ryanodine-sensitive Ca2+ channel in a "Ca2+-induced Ca2+-release" fashion. 

Phrase: "Interestingly,"

Phrase: "extracellular Ca2+-free conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "any additional effect on attenuating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "the Ca2+ elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439775:Elevation [Therapeutic or Preventive Procedure]
   861   C0702240:Elevation [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "preincubation with dantrolene,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that calcium influx from the extracellular space"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3158761:extracellular calcium influx [Cell Function]

Phrase: "may"

Phrase: "serve"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "a larger amount of Ca2+ release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "from the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "through ryanodine-sensitive Ca2+ channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439799:Channel [Spatial Concept]
   812   C1706095:Channel [Conceptual Entity]

Phrase: "in a ""Ca2+-induced Ca2+-release"" fashion."
Processing 00000000.tx.179: Thus, calcium influx from extracellular space may be less than calcium release from intracellular sources such as the endoplasmic reticulum. 

Phrase: "Thus,"

Phrase: "calcium influx from extracellular space"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   844   C3158761:extracellular calcium influx [Cell Function]

Phrase: "may"

Phrase: "be"

Phrase: "less than calcium release"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0439092:Less Than [Intellectual Product]
           less
   770   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0006726:Calcium [Inorganic Chemical]
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0547044:Less [Qualitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]
   770   C2936886:Calcium [Pharmacologic Substance]

Phrase: "from intracellular sources"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449416:sources [Finding]
   827 E C1705919:Source [Idea or Concept]

Phrase: "such as the endoplasmic reticulum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.180: The apoE peptide-mediated increase in phospho-CREB levels and of intracellular Ca2+ levels was inhibited by pretreatment with RAP, MK801, or nifedipine, suggesting that apoE receptors, NMDA receptor, and LVDCC are involved in rat hippocampal neuron responses to apoE. 

Phrase: "The apoE peptide-mediated increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442805:Increase [Functional Concept]

Phrase: "in phospho-CREB levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   845   C1547597:Response level [Idea or Concept]
   795   C0441889:Levels [Qualitative Concept]
   785   C0428479:Protein level [Laboratory or Test Result]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]
   747   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C3158668:cAMP response element binding [Genetic Function]

Phrase: "and of intracellular Ca2+ levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1515981:And [Idea or Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "inhibited by pretreatment"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0311403:Inhibited [Qualitative Concept]
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "with RAP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416920:RAP [Gene or Genome]

Phrase: "MK801,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "nifedipine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028066:Nifedipine [Organic Chemical,Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that apoE receptors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0051300:ApoE Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "NMDA receptor,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080093:NMDA receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1152805:NMDA receptor [Molecular Function]
   861   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "LVDCC"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   913   C0288263:L-Type Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C3538943:L-type calcium channel [Molecular Function]
   827   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   799   C0006726:Calcium [Inorganic Chemical]
   799   C0439799:Channel [Spatial Concept]
   799   C0598352:Voltage [Quantitative Concept]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1701901:Dependent [Qualitative Concept]
   799   C1706095:Channel [Conceptual Entity]
   799   C2936886:Calcium [Pharmacologic Substance]
   799   C3244310:dependent [Functional Concept]

Phrase: "are"

Phrase: "involved in rat hippocampal neuron responses"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   753   C0027882:Neuron [Cell]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0871261:responses [Organism Attribute]
   753   C1314939:Involved [Functional Concept]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "to apoE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]
Processing 00000000.tx.181: Tolar et al. 

Phrase: "Tolar et al."
Processing 00000000.tx.182: (16) reported that RAP and MK801 attenuated the elevation of intracellular Ca2+ caused by truncated apoE. 

Phrase: "(16"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that RAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416920:RAP [Gene or Genome]

Phrase: "and"

Phrase: "MK801"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "the elevation of intracellular Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439775:Elevation [Therapeutic or Preventive Procedure]
   760   C0702240:Elevation [Spatial Concept]

Phrase: "caused by truncated apoE."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.183: They also reported that nifedipine did not provide any protection against the apoE-mediated rise in intracellular Ca2+ in rat hippocampal neurons, but data was not shown. 

Phrase: "They also"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that nifedipine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028066:Nifedipine [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "any protection against the apoE-mediated rise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1545588:Protection [Finding]

Phrase: "in intracellular Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "in rat hippocampal neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "but"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.184: Wang et al. 

Phrase: "Wang et al."
Processing 00000000.tx.185: (26) reported that RAP, MK801, and diltiazem, another inhibitor of LVDCCs, failed to block the apoE peptide-induced calcium influx in rat primary cultured neurons. 

Phrase: "(26"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that RAP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416920:RAP [Gene or Genome]

Phrase: "MK801,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "diltiazem,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012373:Diltiazem [Organic Chemical,Pharmacologic Substance]

Phrase: "another inhibitor of LVDCCs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999216:Inhibitor [Qualitative Concept]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the apoE peptide-induced calcium influx in rat primary cultured neurons."
Processing 00000000.tx.186: Assuming that neurotoxicity is caused by calcium influx following apoE treatment, our data are consistent with the data provided by Tolar et al. 

Phrase: "Assuming"

Phrase: "that neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "is"

Phrase: "caused by calcium influx"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0006726:Calcium [Inorganic Chemical]
   770   C2936886:Calcium [Pharmacologic Substance]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "apoE treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "provided by Tolar et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1999230:Provided [Activity]
Processing 00000000.tx.187: (16) in that RAP and MK801 attenuated calcium influx (16). 

Phrase: "(16"

Phrase: ")"

Phrase: "in"

Phrase: "that RAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416920:RAP [Gene or Genome]

Phrase: "and"

Phrase: "MK801"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "calcium influx"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.188: This result suggests that LRP or some other apoE receptors found in neurons may be linked to NMDA receptor. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that LRP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540560:LRP [Gene or Genome]

Phrase: "or"

Phrase: "some other apoE receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0051300:ApoE Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "found in neurons"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "may"

Phrase: "be"

Phrase: "linked to NMDA receptor."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0080093:NMDA receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1152805:NMDA receptor [Molecular Function]
   770   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
Processing 00000000.tx.189: Our finding that preincubation with nifedipine almost completely inhibited the apoE peptide-induced calcium influx is reasonable because calcium entry through NMDA receptors may depolarize the plasma membrane and open LVDCCs that results in larger amount of calcium influx. 

Phrase: "Our"

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that preincubation with nifedipine almost completely"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the apoE peptide-induced calcium influx"

Phrase: "is"

Phrase: "reasonable"

Phrase: "because"

Phrase: "calcium entry through NMDA receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705654:Entry [Intellectual Product]

Phrase: "may"

Phrase: "depolarize"

Phrase: "the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "open LVDCCs"

Phrase: "that"

Phrase: "results in larger amount of calcium influx."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0006726:Calcium [Inorganic Chemical]
   748   C0443228:larger [Quantitative Concept]
   748   C0549177:Larger [Quantitative Concept]
   748   C1265611:Amount [Quantitative Concept]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1704243:Larger [Quantitative Concept]
   748   C2825142:Result [Finding]
   748   C2936886:Calcium [Pharmacologic Substance]
Processing 00000000.tx.190: Compared with the calcium entry from LVDCCs, calcium entry from NMDA receptors may be negligible (27). 

Phrase: "Compared with the calcium entry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C1705654:Entry [Intellectual Product]
   760   C1707455:Compared [Activity]
   760   C2936886:Calcium [Pharmacologic Substance]

Phrase: "from LVDCCs,"

Phrase: "calcium entry from NMDA receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705654:Entry [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "negligible"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332269:Negligible [Qualitative Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.191: Nevertheless, this calcium elevation can activate kinases such as ERK and calmodulin kinase II that function to phosphorylate CREB (27). 

Phrase: "Nevertheless,"

Phrase: "this calcium elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439775:Elevation [Therapeutic or Preventive Procedure]
   861   C0702240:Elevation [Spatial Concept]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "kinases such as ERK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "calmodulin kinase II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0006776:Calmodulin-Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "phosphorylate"

Phrase: "CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.192: Further inhibition experiments showed that pretreatment with a MEK inhibitor and/or a PKA inhibitor mostly prevented the apoE-peptide stimulated phosphorylation of CREB, suggesting that activation of both MEK and PKA kinases are involved in the pathway. 

Phrase: "Further inhibition experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that pretreatment with a MEK inhibitor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1550147:Pretreatment [Substance]
   744   C2709094:pre treatment [Temporal Concept]
   744   C3539075:Pretreatment [Temporal Concept]
   744   C3539076:Pretreatment [Activity]

Phrase: "and/or"

Phrase: "a PKA inhibitor mostly"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   937   C0243459:Protein Kinase A Inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   888   C1449702:Protein kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   884   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   853   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   853   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   853   C3537023:kinase inhibitor [Molecular Function]
   853   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1999216:Inhibitor [Qualitative Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the apoE-peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "phosphorylation of CREB,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   748   C0031715:Phosphorylation [Molecular Function]
   731   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that activation of both MEK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1155551:MAPK activation [Molecular Function]
   748   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "PKA kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "are"

Phrase: "involved in the pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1314939:Involved [Functional Concept]
   770   C1704259:Pathway [Molecular Function]
   770   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.193: Ca2+ elevation stimulates CREB phosphorylation by activation of a PKA-dependent, Rap1-MEK-ERK pathway (28). 

Phrase: "Ca2+ elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439775:Elevation [Therapeutic or Preventive Procedure]
   861   C0702240:Elevation [Spatial Concept]

Phrase: "stimulates"

Phrase: "CREB phosphorylation by activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   744   C0031715:Phosphorylation [Molecular Function]
   703   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of a PKA-dependent, Rap1-MEK-ERK pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   838   C3179234:ERK Pathway [Cell Function,Molecular Function]
   813   C0037080:Signal Pathway [Molecular Function]
   786   C1704259:Pathway [Molecular Function]
   786   C1705987:Pathway [Conceptual Entity]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.194: Pretreatment with KN62 or SB203580 did not appear to have any effect on the phosphorylation status of CREB, suggesting that the ERK cascade is a major pathway leading the phosphorylation of CREB following apoE treatment. 

Phrase: "Pretreatment with KN62"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "or"

Phrase: "SB203580"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0297666:SB203580 [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "any effect on the phosphorylation status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "of CREB,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the ERK cascade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1707310:Cascade [Manufactured Object]
   750   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   750   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a major pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "leading"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332152:Leading [Temporal Concept]
  1000   C1522538:Leading [Functional Concept]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "the phosphorylation of CREB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   744   C0031715:Phosphorylation [Molecular Function]
   703   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "apoE treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.195: Upon binding to the CRE element of a gene's promoter, the transcription factor known as CREB facilitates transcription of many different genes, such as c-fos, Bcl-2, and BDNF (27, 29-31). 

Phrase: "Upon binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to the CRE element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "of a gene's promoter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the transcription factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "known as CREB"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   897   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C3158668:cAMP response element binding [Genetic Function]
   814   C1511573:cAMP Response Element [Gene or Genome]
   778   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   774 E C0033618:Protein Binding [Molecular Function]
   774   C1148918:cAMP binding [Molecular Function]
   748   C0013879:Element [Element, Ion, or Isotope]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   748   C0205309:Known [Qualitative Concept]
   748   C0243122:binding [Functional Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1704632:Response [Finding]
   748   C1705248:Element [Conceptual Entity]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "facilitates"

Phrase: "transcription of many different genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0040649:genes transcription [Genetic Function]
           Transcription

Phrase: "such as c-fos,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085301:c fos [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0085940:c fos [Gene or Genome]
  1000   C0087140:c-fos [Gene or Genome]

Phrase: "Bcl-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "and"

Phrase: "BDNF"

Phrase: "(27,"

Phrase: "29-31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.196: CREB that actively binds its DNA element, CRE, is typically phosphorylated on serine at position 133.

Phrase: "CREB"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "that actively"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "its DNA element,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "CRE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511573:CRE [Gene or Genome]

Phrase: "is"

Phrase: "typically"

Phrase: "phosphorylated on serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "at position 133."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]
Processing 00000000.tx.197: Activation of CREB by its phosphorylation at serine residue 133is modulated by a variety of effectors. 

Phrase: "Activation of CREB"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   831   C2245434:activation of protein binding [Molecular Function]
   804   C2259194:activation of binding [Molecular Function]
   774   C0599177:protein activation [Genetic Function]
   748   C1879547:Activation [Activity]
   731   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by its phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "at serine residue 133is"

Phrase: "modulated by a variety of effectors."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0443264:Modulated [Spatial Concept]
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]
Processing 00000000.tx.198: -amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) /kainate receptors and NMDA receptors are associated with synapses and LVDCCs are involved in neuronal functions like long-term potentiation (32-34). 

Phrase: "-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   891   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   891   C2917660:Amino Acid [Pharmacologic Substance]
   807   C0033482:propionic acid [Organic Chemical]
   807   C0072186:Propionic acid [Organic Chemical,Pharmacologic Substance]
   791   C0001128:Acid [Chemical]
   791   C0022266:Isoxazole [Organic Chemical]
   791   C0202406:Acid [Laboratory Procedure]
   791   C2945750:propionic [Clinical Attribute]

Phrase: "(AMPA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0051318:AMPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "/kainate receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0064219:Receptors, Kainate [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "NMDA receptors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0080093:NMDA Receptors [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1152805:NMDA receptor [Molecular Function]
   861   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "associated with synapses"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0039062:Synapses [Body Space or Junction]
   756 E C0598501:Synapsis [Cell Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1633000:Synapsis [Plant]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "LVDCCs"

Phrase: "are"

Phrase: "involved in neuronal functions"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0521390:Neuronal [Immunologic Factor]
   770   C0542341:Functions [Functional Concept]
   770   C1314939:Involved [Functional Concept]
   737 E C0031843:function [Physiologic Function]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]

Phrase: "like long-term potentiation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "(32-34"

Phrase: ")."
Processing 00000000.tx.199: Stimulation of these receptors has also been associated with increased intracellular Ca2+ levels, potentiation of kinase activities, and CREB activation. 

Phrase: "Stimulation of these receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "associated with increased intracellular Ca2+ levels,"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0175996:intracellular [Cell Component]
   753   C0178719:Intracellular [Spatial Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   719 E C0456079:Level [Classification]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1547707:Level [Geographic Area]
   719 E C1706221:Associate [Professional or Occupational Group]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "potentiation of kinase activities,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0279023:Potentiation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "CREB activation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0599177:protein activation [Genetic Function]
   799   C1879547:Activation [Activity]
   780   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C3158668:cAMP response element binding [Genetic Function]
Processing 00000000.tx.200: To clarify if calcium influx caused by apoE treatment causes neurotoxicity and parallels phosphorylation of CREB, we measured the elevation of intracellular Ca2+ caused by apoE peptide in rat hippocampal neurons upon exposure to these receptor antagonists. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "if"

Phrase: "calcium influx"

Phrase: "caused by apoE treatment"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "and"

Phrase: "parallels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348042:Parallel [Qualitative Concept]
  1000   C2826345:PARALLEL [Research Activity]

Phrase: "phosphorylation of CREB,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   748   C0031715:Phosphorylation [Molecular Function]
   731   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the elevation of intracellular Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439775:Elevation [Therapeutic or Preventive Procedure]
   760   C0702240:Elevation [Spatial Concept]

Phrase: "caused by apoE peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "in rat hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "upon exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to these receptor antagonists."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0243076:antagonists [Chemical Viewed Functionally]
   827 E C0231491:Antagonist [Organ or Tissue Function]
   755 E C0680242:antagonism [Social Behavior]
Processing 00000000.tx.201: As others has reported (16), treatment of apoE peptide to rat primary hippocampal neurons caused calcium influx and intracellular Ca2+ levels to rise. 

Phrase: "As others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "has"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "treatment of apoE peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "to rat primary hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "calcium influx"

Phrase: "and"

Phrase: "intracellular Ca2+ levels to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "rise."
Processing 00000000.tx.202: Preincubation with RAP, MK801, or nifedipine clearly attenuated the Ca2+ elevation (Fig. 7A), which parallels our data on CREB phosphorylation mediated by apoE peptide, suggesting the involvement of apoE receptor. 

Phrase: "Preincubation with RAP,"

Phrase: "MK801,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813872:MK801 [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "nifedipine clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028066:Nifedipine [Organic Chemical,Pharmacologic Substance]

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "the Ca2+ elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439775:Elevation [Therapeutic or Preventive Procedure]
   861   C0702240:Elevation [Spatial Concept]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "parallels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348042:Parallel [Qualitative Concept]
  1000   C2826345:PARALLEL [Research Activity]

Phrase: "our data on CREB phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1511728:Data Element [Intellectual Product]
   742   C1511726:Data [Idea or Concept]
   742   C3245479:data [Medical Device]

Phrase: "mediated by apoE peptide,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the involvement of apoE receptor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]
Processing 00000000.tx.203: We have shown a possible mechanism whereby apoE4 facilitates the expression of CRE-driven genes and apoE3 does not (Fig. 8). 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a possible mechanism whereby apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   812   C2984964:APOE4 [Laboratory Procedure]

Phrase: "facilitates"

Phrase: "the expression of CRE-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "does"

Phrase: "not (Fig. 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]
   827   C1518422:Not [Functional Concept]

Phrase: ")."
Processing 00000000.tx.204: We hypothesize that apoE4, which stimulates CREB phosphorylation, may be associated with synaptic plasticity. 

Phrase: "We"

Phrase: "hypothesize"

Phrase: "that apoE4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "which"

Phrase: "stimulates"

Phrase: "CREB phosphorylation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   799   C0031715:Phosphorylation [Molecular Function]
   780   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C3158668:cAMP response element binding [Genetic Function]

Phrase: "may"

Phrase: "be"

Phrase: "associated with synaptic plasticity."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0678558:Plasticity [Natural Phenomenon or Process]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.205: This apparent isoform specificity of the effects might be relevant to the isoform-specific association of apoE4 as a significant risk factor in late-onset Alzheimer's disease. 

Phrase: "This apparent isoform specificity of the effects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037791:Specificity [Quantitative Concept]
   748   C1511884:Specificity [Quantitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "relevant to the isoform-specific association of apoE4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2347946:Relevant [Qualitative Concept]

Phrase: "as a significant risk factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0035648:Risk factor [Quantitative Concept]
   827   C0035647:Risk [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "in late-onset Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.206: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.207: 8.  

Phrase: "8."
Processing 00000000.tx.208: A model of apoE-mediated CREB activation in hippocampal neurons. 

Phrase: "A model of apoE-mediated CREB activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C3161035:Model [Intellectual Product]

Phrase: "in hippocampal neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.209: When apoE4, but not apoE3, binds to apoE receptor on the surface of hippocampal neuron, NMDA receptors open. 

Phrase: "When"

Phrase: "apoE4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "but"

Phrase: "not apoE3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "binds to apoE receptor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0051300:ApoE Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0523511:APOE [Laboratory Procedure]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1412481:APOE [Gene or Genome]

Phrase: "on the surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205148:Surface [Spatial Concept]

Phrase: "of hippocampal neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "NMDA receptors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0080093:NMDA Receptors [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1152805:NMDA receptor [Molecular Function]
   861   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "open."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175566:Open [Spatial Concept]
Processing 00000000.tx.210: Its mechanism is unclear. 

Phrase: "Its mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.211: Activation of NMDA receptor causes small amounts of Ca2+ entry into postsynaptic spines. 

Phrase: "Activation of NMDA receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1514758:Receptor Activation [Cell Function]
   770   C1879547:Activation [Activity]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "small amounts of Ca2+ entry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "into postsynaptic spines."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0037949:spines [Body Part, Organ, or Organ Component]
   827 E C1267072:Spine [Body Part, Organ, or Organ Component]
   827 E C1280065:Spine [Body Part, Organ, or Organ Component]
   827 E C2752558:spine [Cell Component]
   777 E C0521329:Spinal [Spatial Concept]
Processing 00000000.tx.212: The resulting depolarization triggers the opening of L-type voltage-dependent calcium channels exist in cytoplasmic membranes of the neurons. 

Phrase: "The resulting depolarization"

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "the opening of L-type voltage-dependent calcium channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0175566:Opening [Spatial Concept]
   742   C1882151:Opening [Spatial Concept]

Phrase: "exist in cytoplasmic membranes of the neurons."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0007603:Membranes, Cytoplasmic [Cell Component]
   748   C0010834:Cytoplasmic [Cell Component]
   748   C0025255:Membranes [Tissue]
   748   C0027882:Neurons [Cell]
   748   C0521449:Cytoplasmic [Body Location or Region]
   748   C2987476:Exist [Conceptual Entity]
   714 E C0596901:Membrane [Cell Component]
   714 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.213: The activation of L-type voltage-dependent calcium channels, which is open during strong depolarization, permit the entry of larger amount of Ca2+ along the dendrites and into the cell bodies, causing the opening of ryanodine-sensitive Ca2+ channel on ER membrane and the influx of larger amount of Ca2+ from ER in Ca2+-induced Ca2+ release fashion. 

Phrase: "The activation of L-type voltage-dependent calcium channels,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1879547:Activation [Activity]

Phrase: "which"

Phrase: "is"

Phrase: "open during strong depolarization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0175566:Open [Spatial Concept]

Phrase: "permit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "the entry of larger amount of Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705654:Entry [Intellectual Product]

Phrase: "along the dendrites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011305:Dendrites [Cell Component]

Phrase: "and into the cell bodies,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   797   C0599444:bodies cell [Cell Component]
   773 E C2752549:cell body [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0242821:bodies [Human]
   760   C1269647:Cell [Cell]
   760   C1515981:And [Idea or Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C1995017:Bodies [Cell Component]
   726 E C0460148:Body [Anatomical Structure]
   726 E C1268086:Body [Anatomical Structure]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "the opening of ryanodine-sensitive Ca2+ channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0175566:Opening [Spatial Concept]
   748   C1882151:Opening [Spatial Concept]

Phrase: "on ER membrane"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0230770:endoplasmic reticulum membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "and"

Phrase: "the influx of larger amount of Ca2+"

Phrase: "from ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "in Ca2+-induced Ca2+ release fashion."
Processing 00000000.tx.214: The Ca2+ entry from extracellular space may be negligible, comparing that from ER calcium elevation allows activation of PKA-dependent Rap1-ERK pathway and phosphorylation of CREB.  

Phrase: "The Ca2+ entry from extracellular space"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705654:Entry [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "negligible,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332269:Negligible [Qualitative Concept]

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "that from ER calcium elevation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   753   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006726:Calcium [Inorganic Chemical]
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   753   C0439775:Elevation [Therapeutic or Preventive Procedure]
   753   C0702240:Elevation [Spatial Concept]
   753   C2936886:Calcium [Pharmacologic Substance]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of PKA-dependent Rap1-ERK pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   824   C0037080:Signal Pathway [Molecular Function]
   790   C1704259:Pathway [Molecular Function]
   790   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "phosphorylation of CREB."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   748   C0031715:Phosphorylation [Molecular Function]
   731   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.215: ACKNOWLEDGEMENTS We thank Drs. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs."
Processing 00000000.tx.216: Kazunori Imaizumi, Yongho Che, Shin-ichi Miyake, and Hideo Matsuzaki for helpful and informative discussions, and Yumiko Hara for technical assistance.  

Phrase: "Kazunori Imaizumi,"

Phrase: "Yongho Che,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039021:CHE [Geographic Area]

Phrase: "Shin-ichi Miyake,"

Phrase: "and"

Phrase: "Hideo Matsuzaki for helpful"

Phrase: "and"

Phrase: "informative discussions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0557061:discussions [Therapeutic or Preventive Procedure]
   827 E C2584313:Discussion [Social Behavior]

Phrase: "and"

Phrase: "Yumiko Hara for technical assistance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2758676:Hara [Fish]
Processing 00000000.tx.217: FOOTNOTES * This work was supported by grants from CREST JST (Japan Science and Technology), the Ministry of Education, Science, Sports and Culture of Japan, the Novartis Foundation for Gerontological Research, and the United States National Institute on Aging.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from CREST JST"

Phrase: "(Japan Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Technology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039421:Technology [Occupation or Discipline]

Phrase: ")"

Phrase: ","

Phrase: "the Ministry of Education,"

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "Sports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038039:Sports [Daily or Recreational Activity]
  1000   C1552306:Sports [Professional or Occupational Group]

Phrase: "and"

Phrase: "Culture of Japan,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0010453:Culture [Idea or Concept]
   790   C0220814:culture [Functional Concept]
   790   C0430400:Culture [Laboratory Procedure]
   790   C2242979:Culture [Laboratory Procedure]

Phrase: "the Novartis Foundation for Gerontological Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0016617:Foundation [Organization]
   742   C2986512:Research Base [Organization]

Phrase: "and"

Phrase: "the United States National Institute on Aging."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C1955974:National Institute on Aging [Health Care Related Organization]
   799   C0001811:Ageing [Organism Function]
   799   C0021622:institute [Organization]
   799   C1272753:Institute [Idea or Concept]
   799   C3245503:national [Intellectual Product]
   766 E C0001779:Age [Organism Attribute]
Processing 00000000.tx.218: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.219: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.220: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.221: To whom correspondence should be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.222: Dept. of Anatomy and Neuroscience, Graduate School of Medicine, Osaka University, 2-2Yamadaoka, Suita, Osaka 565-0871,Japan. 

Phrase: "Dept."

Phrase: "of Anatomy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0002808:Anatomy [Biomedical Occupation or Discipline]
  1000   C0700276:anatomy [Anatomical Structure]
  1000   C1384516:anatomy [Qualitative Concept]
   928 E C0220784:Anatomical [Qualitative Concept]

Phrase: "and"

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "Graduate School of Medicine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0870614:graduate school [Manufactured Object,Organization]
   770   C0036375:School [Manufactured Object,Organization]
   770   C0588053:Graduate [Population Group]
   770   C1547183:Graduate [Idea or Concept]

Phrase: "Osaka University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "2-2Yamadaoka,"

Phrase: "Suita,"

Phrase: "Osaka 565-0871,"

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.223: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.224: 81-6-6879-3221; 

Phrase: "81-6-6879-3221"

Phrase: ";"
Processing 00000000.tx.225: Fax: 81-6-6879-3229; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "81-6-6879-3229"

Phrase: ";"
Processing 00000000.tx.226: E-mail: mitsuda@anat2.med.osaka-u.ac.jp. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "mitsuda@anat2.med.osaka-u.ac.jp."
Processing 00000000.tx.227: Published, JBC Papers in Press, October 20,2000,DOI 10.1074/jbc.M005070200  ABBREVIATIONS The abbreviations used are: APOE, apolipoprotein-E; 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "October 20,"

Phrase: "2000,"

Phrase: "DOI 10.1074/jbc.M005070200  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "APOE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "apolipoprotein-E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.228: AP1, activator protein 1; 

Phrase: "AP1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3536909:AP1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "activator protein 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0085828:Activator Protein-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812312:activator protein 1 [Gene or Genome]
  1000   C1333571:activator protein 1 [Gene or Genome]
  1000   C3536909:Activator Protein 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1419349:activator 1 [Gene or Genome]
   901   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.229: CRE, cAMP response element; 

Phrase: "CRE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511573:CRE [Gene or Genome]

Phrase: "cAMP response element"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1511573:cAMP Response Element [Gene or Genome]
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: ";"
Processing 00000000.tx.230: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.231: TNF-, tumor necrosis factor-; 

Phrase: "TNF-,"

Phrase: "tumor necrosis factor-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: ";"
Processing 00000000.tx.232: SEAP, secreted alkaline phosphatase; 

Phrase: "SEAP,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1412365:SECRETED ALKALINE PHOSPHATASE [Gene or Genome]
   901   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1149880:phosphatase [Molecular Function]
   827   C1327616:Secreted [Cell Function]
   827   C1979842:Alkaline [Qualitative Concept]

Phrase: "secreted alkaline phosphatase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1412365:SECRETED ALKALINE PHOSPHATASE [Gene or Genome]
   901   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1149880:phosphatase [Molecular Function]
   827   C1327616:Secreted [Cell Function]
   827   C1979842:Alkaline [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.233: NMDA, N-methyl-D-asparatate; 

Phrase: "NMDA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079883:NMDA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "N-methyl-"

Phrase: "D-"

Phrase: "asparatate"

Phrase: ";"
Processing 00000000.tx.234: LVDCC, L-type voltage-dependent calcium channel; 

Phrase: "LVDCC,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   913   C0288263:L-Type Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C3538943:L-type calcium channel [Molecular Function]
   827   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   799   C0006726:Calcium [Inorganic Chemical]
   799   C0439799:Channel [Spatial Concept]
   799   C0598352:Voltage [Quantitative Concept]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1701901:Dependent [Qualitative Concept]
   799   C1706095:Channel [Conceptual Entity]
   799   C2936886:Calcium [Pharmacologic Substance]
   799   C3244310:dependent [Functional Concept]

Phrase: "L-type voltage-dependent calcium channel"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   913   C0288263:L-Type Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C3538943:L-type calcium channel [Molecular Function]
   827   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   799   C0006726:Calcium [Inorganic Chemical]
   799   C0439799:Channel [Spatial Concept]
   799   C0598352:Voltage [Quantitative Concept]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1701901:Dependent [Qualitative Concept]
   799   C1706095:Channel [Conceptual Entity]
   799   C2936886:Calcium [Pharmacologic Substance]
   799   C3244310:dependent [Functional Concept]

Phrase: ";"
Processing 00000000.tx.235: ERK, extracellular signal-regulated kinase; 

Phrase: "ERK,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   979   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   979   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0521119:Extracellular [Cell Component]
   812   C0851285:Regulated [Governmental or Regulatory Activity]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "extracellular signal-regulated kinase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   979   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   979   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0521119:Extracellular [Cell Component]
   812   C0851285:Regulated [Governmental or Regulatory Activity]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.236: MEK, mitogen-activated protein kinase/extracellular signal-regulated kinase; 

Phrase: "MEK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   972   C0752313:MAPK-ERK Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   871   C0169101:MAPK Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mitogen-activated protein kinase/extracellular signal-regulated kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   876   C0169101:Mitogen-Activated Protein Kinase Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0521119:Extracellular [Cell Component]
   793   C0851285:Regulated [Governmental or Regulatory Activity]
   793   C1710082:Signal [Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.237: PAGE, polyacrylamide gel electrophoresis; 

Phrase: "PAGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "polyacrylamide gel electrophoresis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: ";"
Processing 00000000.tx.238: PKA, protein kinase A; 

Phrase: "PKA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protein kinase A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.239: ER, endoplasmic reticulum; 

Phrase: "ER,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: ";"
Processing 00000000.tx.240: HSE, heat shock element; 

Phrase: "HSE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1537381:HSE [Gene or Genome]
  1000   C3540642:HSE [Gene or Genome]

Phrase: "heat shock element"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0282498:Heat Shock [Physiologic Function]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0018837:Heat [Natural Phenomenon or Process]
   827   C0036974:Shock [Pathologic Function]
   827   C1705248:Element [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.241: CREB, CRE-binding protein.  

Phrase: "CREB,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "CRE-binding protein."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0056695:CRE Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C3158668:CRE binding [Genetic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
Processing 00000000.tx.242: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.243: Sisodia, S. 

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.244: S., Koo, E. 

Phrase: "S."

Phrase: ","

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.245: H., Beyreuther, K., Unterbeck, A., and Price, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Unterbeck,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.246: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.247: (1990) Science 248, 492-495[Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Science 248,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "492-495"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.248: Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. 

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.249: Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., and Selkoe, D. 

Phrase: "Y.,"

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.250: J. 

Phrase: "J."
Processing 00000000.tx.251: (1992) Nature 360, 672-674[CrossRef][Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 360,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "672-674"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.252: Suzuki, N., Cheung, T. 

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cheung,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.253: T., Cai, X. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."
Processing 00000000.tx.254: D., Odaka, A., Otvos, L., Eckman, C., Golde, T. 

Phrase: "D."

Phrase: ","

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.255: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.256: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.257: (1994) Science 264, 1336-1340[Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Science 264,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1336-1340"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.258: Selkoe, D. 

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.259: J. 

Phrase: "J."
Processing 00000000.tx.260: (1994) Annu. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.261: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.262: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.263: 10, 373-403[CrossRef] 5. 

Phrase: "10,"

Phrase: "373-403"

Phrase: "[CrossRef"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.264: Sherrington, R., Rogaev, E. 

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaev,"

Phrase: "E."
Processing 00000000.tx.265: I., Liang, Y., Rogaeva, E. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Rogaeva,"

Phrase: "E."
Processing 00000000.tx.266: A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J. 

Phrase: "A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mar"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Foncin,"

Phrase: "J."
Processing 00000000.tx.267: F., Bruni, A. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bruni,"

Phrase: "A."
Processing 00000000.tx.268: C., Montesi, M. 

Phrase: "C., Montesi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.269: P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brooks, A., Sanseau, P., Pollinsky, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sorbi,"

Phrase: "S."

Phrase: ","

Phrase: "Rainero,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pinessi,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Nee,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chumakov,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pollen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032385:Pollen [Plant]
  1000   C0795585:POLLEN [Organic Chemical,Pharmacologic Substance]
  1000   C1320238:Pollen [Immunologic Factor]

Phrase: "D."

Phrase: ","

Phrase: "Brooks,"

Phrase: "A.,"

Phrase: "Sanseau,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Pollinsky,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.270: J., Wasco, W., Da Silva, H. 

Phrase: "J.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Da Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.271: A.R., Haines, J. 

Phrase: "A.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Haines,"

Phrase: "J."
Processing 00000000.tx.272: L., Pericack-Vance, M. 

Phrase: "L., Pericack-Vance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.273: A., Tanzi, R. 

Phrase: "A.,"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.274: E., Roses, A. 

Phrase: "E.,"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.275: D., Fraser, P. 

Phrase: "D."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.276: E., Rommens, J. 

Phrase: "E.,"

Phrase: "Rommens,"

Phrase: "J."
Processing 00000000.tx.277: M., and St. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.278: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.279: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.280: (1995) Nature 375, 754-760[CrossRef][Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 375,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "754-760"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.281: Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. 

Phrase: "Levy-Lahad,"

Phrase: "E.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Romano,"

Phrase: "D."
Processing 00000000.tx.282: M., Oshima, J., Pettingell, W. 

Phrase: "M."

Phrase: ","

Phrase: "Oshima,"

Phrase: "J.,"

Phrase: "Pettingell,"

Phrase: "W."
Processing 00000000.tx.283: H., Yu, C.E., Jondro, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Jondro,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.284: D., Schmidt, S. 

Phrase: "D."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.285: D., Wang, K., Crowley, A. 

Phrase: "D."

Phrase: ","

Phrase: "Wang,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Crowley,"

Phrase: "A."
Processing 00000000.tx.286: C., Fu, Y. 

Phrase: "C., Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C1424823:FU [Gene or Genome]

Phrase: "Y."
Processing 00000000.tx.287: H., Guenette, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.288: Y., Galas, D., Nemens, E., Wijsman, E. 

Phrase: "Y.,"

Phrase: "Galas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0082651:gala [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966   C1439334:GALA [Gene or Genome]

Phrase: "D."

Phrase: ","

Phrase: "Nemens,"

Phrase: "E.,"

Phrase: "Wijsman,"

Phrase: "E."
Processing 00000000.tx.289: M., Bird, T. 

Phrase: "M."

Phrase: ","

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.290: D., Schellenberg, G. 

Phrase: "D."

Phrase: ","

Phrase: "Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.291: D., and Tanzi, R. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.292: E. 

Phrase: "E."
Processing 00000000.tx.293: (1995) Science 269, 973-977[Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 269,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "973-977"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.294: Levy-Lahad, E., Wijsman, E. 

Phrase: "Levy-Lahad,"

Phrase: "E.,"

Phrase: "Wijsman,"

Phrase: "E."
Processing 00000000.tx.295: M., Nemens, E., Anderson, L., Goddard, K. 

Phrase: "M."

Phrase: ","

Phrase: "Nemens,"

Phrase: "E.,"

Phrase: "Anderson,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Goddard,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.296: A., Weber, J. 

Phrase: "A.,"

Phrase: "Weber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:weber [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.297: L., Bird, T. 

Phrase: "L., Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.298: D., and Schellenberg, G. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.299: D. 

Phrase: "D."
Processing 00000000.tx.300: (1995) Science 269, 970-973[Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 269,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "970-973"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.301: Corder, E. 

Phrase: "Corder,"

Phrase: "E."
Processing 00000000.tx.302: H., Saunders, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.303: M., Strittmatter, W. 

Phrase: "M."

Phrase: ","

Phrase: "Strittmatter,"

Phrase: "W."
Processing 00000000.tx.304: J., Schmechel, D. 

Phrase: "J.,"

Phrase: "Schmechel,"

Phrase: "D."
Processing 00000000.tx.305: E., Gaskel, P. 

Phrase: "E.,"

Phrase: "Gaskel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.306: C., Small, G. 

Phrase: "C., Small, G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.307: W., Roses, A. 

Phrase: "W., Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035853:Roses [Plant]
   827 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.308: D., Haines, J. 

Phrase: "D."

Phrase: ","

Phrase: "Haines,"

Phrase: "J."
Processing 00000000.tx.309: L., and Pericak-Vance, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Pericak-Vance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.310: A. 

Phrase: "A."
Processing 00000000.tx.311: (1993) Science 261, 921-923[Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Science 261,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "921-923"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.312: Corder, E. 

Phrase: "Corder,"

Phrase: "E."
Processing 00000000.tx.313: H., Saunders, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.314: M., Risch, N. 

Phrase: "M."

Phrase: ","

Phrase: "Risch,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.315: J., Strittmatter, W. 

Phrase: "J.,"

Phrase: "Strittmatter,"

Phrase: "W."
Processing 00000000.tx.316: J., Schmechel, D. 

Phrase: "J.,"

Phrase: "Schmechel,"

Phrase: "D."
Processing 00000000.tx.317: E., Gaskel, P. 

Phrase: "E.,"

Phrase: "Gaskel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.318: C., Rimmler, J. 

Phrase: "C., Rimmler,"

Phrase: "J."
Processing 00000000.tx.319: B., Locke, P. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Locke,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.320: A., Conneally, P. 

Phrase: "A.,"

Phrase: "Conneally,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.321: M., Schmader, K. 

Phrase: "M."

Phrase: ","

Phrase: "Schmader,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.322: E., Small, G. 

Phrase: "E.,"

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.323: W., Roses, A. 

Phrase: "W., Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035853:Roses [Plant]
   827 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.324: D., Haines, J. 

Phrase: "D."

Phrase: ","

Phrase: "Haines,"

Phrase: "J."
Processing 00000000.tx.325: L., and Pericak-Vance, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Pericak-Vance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.326: A. 

Phrase: "A."
Processing 00000000.tx.327: (1994) Nat. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.328: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.329: 7, 180-184[Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "7,"

Phrase: "180-184"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.330: Strittmatter, W. 

Phrase: "Strittmatter,"

Phrase: "W."
Processing 00000000.tx.331: J., Saunders, A. 

Phrase: "J.,"

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.332: M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. 

Phrase: "M."

Phrase: ","

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Enghild,"

Phrase: "J.,"

Phrase: "Salvesen,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.333: S., and Roses, A. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.334: D. 

Phrase: "D."
Processing 00000000.tx.335: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.336: Natl. 

Phrase: "Natl."
Processing 00000000.tx.337: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.338: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.339: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1704253:U Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.340: 90, 1977-1981[Abstract] 11. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "1977-1981"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 11."
Processing 00000000.tx.341: Mahley, R. 

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.342: W. 

Phrase: "W."
Processing 00000000.tx.343: (1988) Science 240, 622-630[Medline] [OrderarticleviaInfotrieve] 12. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Science 240,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "622-630"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 12."
Processing 00000000.tx.344: Marques, M. 

Phrase: "Marques,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.345: A., Tolar, M., Harmony, J. 

Phrase: "A.,"

Phrase: "Tolar,"

Phrase: "M."

Phrase: ","

Phrase: "Harmony,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699798:harmony [Social Behavior]
  1000   C2945637:harmony [Finding]

Phrase: "J."
Processing 00000000.tx.346: A., and Crutcher, K. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Crutcher,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.347: A. 

Phrase: "A."
Processing 00000000.tx.348: (1996) Neuroreport 7, 2529-2532[Medline] [OrderarticleviaInfotrieve] 13. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuroreport 7,"

Phrase: "2529-2532"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 13."
Processing 00000000.tx.349: Jordan, J., Galindo, M. 

Phrase: "Jordan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022418:Jordan [Geographic Area]

Phrase: "J.,"

Phrase: "Galindo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.350: F., Miller, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.351: J., Reardon, C. 

Phrase: "J.,"

Phrase: "Reardon,"

Phrase: "C."
Processing 00000000.tx.352: A., Getz, G. 

Phrase: "A.,"

Phrase: "Getz,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.353: S., and LaDu, M. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "LaDu,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.354: J. 

Phrase: "J."
Processing 00000000.tx.355: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.356: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.357: 18, 195-204[Abstract/Free FullText] 14. 

Phrase: "18,"

Phrase: "195-204"

Phrase: "[Abstract/Free FullText"

Phrase: "] 14."
Processing 00000000.tx.358: Tolar, M., Marques, M. 

Phrase: "Tolar,"

Phrase: "M."

Phrase: ","

Phrase: "Marques,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.359: A., Harmony, J. 

Phrase: "A.,"

Phrase: "Harmony,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699798:harmony [Social Behavior]
  1000   C2945637:harmony [Finding]

Phrase: "J."
Processing 00000000.tx.360: A.K., and Crutcher, K. 

Phrase: "A.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0313240:antibody k [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Crutcher,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.361: A. 

Phrase: "A."
Processing 00000000.tx.362: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.363: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.364: 17, 5678-5686[Abstract/Free FullText] 15. 

Phrase: "17,"

Phrase: "5678-5686"

Phrase: "[Abstract/Free FullText"

Phrase: "] 15."
Processing 00000000.tx.365: Moulder, K. 

Phrase: "Moulder"

Phrase: ","

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.366: L., Narita, M., Chang, L. 

Phrase: "L., Narita,"

Phrase: "M."

Phrase: ","

Phrase: "Chang,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.367: K., Bu, G., and Johnson, E. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006463:BU [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Johnson,"

Phrase: "E."
Processing 00000000.tx.368: M., Jr. 

Phrase: "M."

Phrase: ","

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.369: (1999) Neurochem. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neurochem."
Processing 00000000.tx.370: 72, 1069-1080[CrossRef] 16. 

Phrase: "72,"

Phrase: "1069-1080"

Phrase: "[CrossRef"

Phrase: "] 16."
Processing 00000000.tx.371: Tolar, M., Keller, J. 

Phrase: "Tolar,"

Phrase: "M."

Phrase: ","

Phrase: "Keller,"

Phrase: "J."
Processing 00000000.tx.372: N., Chan, S., Mattson, M. 

Phrase: "N., Chan,"

Phrase: "S."

Phrase: ","

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.373: P., Marques, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Marques,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.374: A., and Crutcher, K. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Crutcher,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.375: A. 

Phrase: "A."
Processing 00000000.tx.376: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.377: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.378: 19, 7100-7110[Abstract/Free FullText] 17. 

Phrase: "19,"

Phrase: "7100-7110"

Phrase: "[Abstract/Free FullText"

Phrase: "] 17."
Processing 00000000.tx.379: Clay, M. 

Phrase: "Clay,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0055863:clay [Inorganic Chemical]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.380: A., Anantharamaiah, G. 

Phrase: "A.,"

Phrase: "Anantharamaiah,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.381: M., Mistry, M. 

Phrase: "M."

Phrase: ","

Phrase: "Mistry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.382: J., Balasubramaniam, A., and Harmony, J. 

Phrase: "J.,"

Phrase: "Balasubramaniam,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Harmony,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699798:harmony [Social Behavior]
  1000   C2945637:harmony [Finding]

Phrase: "J."
Processing 00000000.tx.383: A. 

Phrase: "A."
Processing 00000000.tx.384: (1995) Biochemistry 34, 11142-11151[Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Biochemistry 34,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "11142-11151"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.385: Tamatani, M., Che, Y. 

Phrase: "Tamatani,"

Phrase: "M."

Phrase: ","

Phrase: "Che,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:CHE [Geographic Area]

Phrase: "Y."
Processing 00000000.tx.386: H., Matsuzaki, H., Ogawa, S., Okado, H., Miyake, S., Mizuno, T., and Tohyama, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Matsuzaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ogawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443037:Ogawa [Intellectual Product]

Phrase: "S."

Phrase: ","

Phrase: "Okado,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Miyake,"

Phrase: "S."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Tohyama,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.387: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.388: Biol. 

Phrase: "Biol."
Processing 00000000.tx.389: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.390: 274, 8531-8538[Abstract/Free FullText] 19. 

Phrase: "274,"

Phrase: "8531-8538"

Phrase: "[Abstract/Free FullText"

Phrase: "] 19."
Processing 00000000.tx.391: McCarthy, K. 

Phrase: "McCarthy,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.392: D., and de Vellis, J. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "de Vellis,"

Phrase: "J."
Processing 00000000.tx.393: (1980) J. 

Phrase: "(1980"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.394: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.395: 85, 890-902[Abstract] 20. 

Phrase: "85,"

Phrase: "890-902"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 20."
Processing 00000000.tx.396: Laskowitz, D. 

Phrase: "Laskowitz,"

Phrase: "D."
Processing 00000000.tx.397: T., Goel, S., Bennett, E. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Goel,"

Phrase: "S."

Phrase: ","

Phrase: "Bennett,"

Phrase: "E."
Processing 00000000.tx.398: R., and Matthew, W. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Matthew,"

Phrase: "W."
Processing 00000000.tx.399: D. 

Phrase: "D."
Processing 00000000.tx.400: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.401: Neuroimmunol. 

Phrase: "Neuroimmunol."
Processing 00000000.tx.402: 76, 70-74[CrossRef][Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "76,"

Phrase: "70-74"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.403: Gonzalez, G. 

Phrase: "Gonzalez,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.404: A., and Montminy, M. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Montminy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.405: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.406: (1989) Cell 59, 675-680[Medline] [OrderarticleviaInfotrieve] 22. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Cell 59,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "675-680"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 22."
Processing 00000000.tx.407: Ginty, D. 

Phrase: "Ginty,"

Phrase: "D."
Processing 00000000.tx.408: D., Bonni, A., and Greenberg, M. 

Phrase: "D."

Phrase: ","

Phrase: "Bonni,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Greenberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.409: E. 

Phrase: "E."
Processing 00000000.tx.410: (1994) Cell 77, 713-725[Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Cell 77,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "713-725"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.411: Sun, Y., Wu, S., Bu, G., Onifade, M. 

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "Y.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "S."

Phrase: ","

Phrase: "Bu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006463:BU [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Onifade,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.412: K., Patel, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Patel,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.413: N., LaDu, M. 

Phrase: "N., LaDu,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.414: J., Fagan, A. 

Phrase: "J.,"

Phrase: "Fagan,"

Phrase: "A."
Processing 00000000.tx.415: M., and Holtzman, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Holtzman,"

Phrase: "D."
Processing 00000000.tx.416: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.417: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.418: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.419: 18, 3261-3272[Abstract/Free FullText] 24. 

Phrase: "18,"

Phrase: "3261-3272"

Phrase: "[Abstract/Free FullText"

Phrase: "] 24."
Processing 00000000.tx.420: Poirier, J., Minnich, A., and Davignon, J. 

Phrase: "Poirier,"

Phrase: "J.,"

Phrase: "Minnich,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Davignon,"

Phrase: "J."
Processing 00000000.tx.421: (1995) Ann. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.422: Med. 

Phrase: "Med."
Processing 00000000.tx.423: 27, 663-70[Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "27,"

Phrase: "663-70"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.424: Matsuzaki, H., Tamatani, M., Mitsuda, N., Namikawa, K., Kiyama, H., Miyake, S., and Tohyama, M. 

Phrase: "Matsuzaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tamatani,"

Phrase: "M."

Phrase: ","

Phrase: "Mitsuda,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Namikawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kiyama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Miyake,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Tohyama,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.425: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.426: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.427: 73, 2037-2046[Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "73,"

Phrase: "2037-2046"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.428: Wang, X. 

Phrase: "Wang,"

Phrase: "X."
Processing 00000000.tx.429: S., and Gruenstein, E. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Gruenstein,"

Phrase: "E."
Processing 00000000.tx.430: (1997) Cell Physiol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Cell Physiol."
Processing 00000000.tx.431: 173, 73-83[CrossRef] 27. 

Phrase: "173,"

Phrase: "73-83"

Phrase: "[CrossRef"

Phrase: "] 27."
Processing 00000000.tx.432: Rajadhyaksha, A., Barczak, A., Macias, W., Leveque, J. 

Phrase: "Rajadhyaksha,"

Phrase: "A.,"

Phrase: "Barczak,"

Phrase: "A.,"

Phrase: "Macias,"

Phrase: "W.,"

Phrase: "Leveque,"

Phrase: "J."
Processing 00000000.tx.433: C., Lewis, S. 

Phrase: "C., Lewis,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.434: E., and Konradi, C. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Konradi,"

Phrase: "C."
Processing 00000000.tx.435: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.436: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.437: 19, 6348-6359[Abstract/Free FullText] 28. 

Phrase: "19,"

Phrase: "6348-6359"

Phrase: "[Abstract/Free FullText"

Phrase: "] 28."
Processing 00000000.tx.438: Grewal, S. 

Phrase: "Grewal,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.439: S., Fass, D. 

Phrase: "S."

Phrase: ","

Phrase: "Fass,"

Phrase: "D."
Processing 00000000.tx.440: M., Yao, H., Ellig, C. 

Phrase: "M."

Phrase: ","

Phrase: "Yao,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ellig,"

Phrase: "C."
Processing 00000000.tx.441: L., Goodman, R. 

Phrase: "L., Goodman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.442: H., and Stork, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Stork,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325459:Stork [Bird]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.443: J.S. 

Phrase: "J.S."
Processing 00000000.tx.444: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.445: Biol. 

Phrase: "Biol."
Processing 00000000.tx.446: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.447: 275, 34433-34441[Abstract/Free FullText] 29. 

Phrase: "275,"

Phrase: "34433-34441"

Phrase: "[Abstract/Free FullText"

Phrase: "] 29."
Processing 00000000.tx.448: Riccio, A., Ahn, S., Davenport, C. 

Phrase: "Riccio,"

Phrase: "A.,"

Phrase: "Ahn,"

Phrase: "S."

Phrase: ","

Phrase: "Davenport,"

Phrase: "C."
Processing 00000000.tx.449: M., Blendy, J. 

Phrase: "M."

Phrase: ","

Phrase: "Blendy,"

Phrase: "J."
Processing 00000000.tx.450: A., and Ginty, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Ginty,"

Phrase: "D."
Processing 00000000.tx.451: D. 

Phrase: "D."
Processing 00000000.tx.452: (1999) Science 286, 2358-2361[Abstract/Free FullText] 30. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Science 286,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "2358-2361"

Phrase: "[Abstract/Free FullText"

Phrase: "] 30."
Processing 00000000.tx.453: Shieh, P. 

Phrase: "Shieh,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.454: B., Hu, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hu,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.455: C., Bobb, K., Timmusk, T., and Ghosh, A. 

Phrase: "C., Bobb,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Timmusk,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Ghosh,"

Phrase: "A."
Processing 00000000.tx.456: (1998) Neuron 20, 727-740[Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neuron 20,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "727-740"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.457: Tao, X., Finkbeiner, S., Arnold, D. 

Phrase: "Tao,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   944   C0041165:Troleandomycin [Antibiotic,Organic Chemical]
   916 E C0040021:taos [Disease or Syndrome]
   916 E C1551534:Taos [Population Group]

Phrase: "X.,"

Phrase: "Finkbeiner,"

Phrase: "S."

Phrase: ","

Phrase: "Arnold,"

Phrase: "D."
Processing 00000000.tx.458: B., Shaywitz, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Shaywitz,"

Phrase: "A."
Processing 00000000.tx.459: J., and Greenberg, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Greenberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.460: E. 

Phrase: "E."
Processing 00000000.tx.461: (1998) Neuron 20, 709-726[Medline] [OrderarticleviaInfotrieve] 32. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neuron 20,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "709-726"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 32."
Processing 00000000.tx.462: Fantaske, R., Ogden, A., Gates, M., Ornstein, P. 

Phrase: "Fantaske,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ogden,"

Phrase: "A.,"

Phrase: "Gates,"

Phrase: "M."

Phrase: ","

Phrase: "Ornstein,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.463: L., Lodge, D., Bleakman, D., and Collingridge, G. 

Phrase: "L., Lodge,"

Phrase: "D."

Phrase: ","

Phrase: "Bleakman,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Collingridge,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.464: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.465: (1999) Nature 402, 297-301[CrossRef][Medline] [OrderarticleviaInfotrieve] 33. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 402,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "297-301"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 33."
Processing 00000000.tx.466: Tsien, J. 

Phrase: "Tsien,"

Phrase: "J."
Processing 00000000.tx.467: Z., Huerta, P. 

Phrase: "Z.,"

Phrase: "Huerta,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.468: T., and Tonegawa, S. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Tonegawa,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.469: (1996) Cell 87, 1327-1338[Medline] [OrderarticleviaInfotrieve] 34. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cell 87,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1327-1338"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 34."
Processing 00000000.tx.470: Weisskopf, M. 

Phrase: "Weisskopf,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.471: G., Bauer, E. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bauer,"

Phrase: "E."
Processing 00000000.tx.472: P., and LeDoux, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "LeDoux,"

Phrase: "J."
Processing 00000000.tx.473: E. 

Phrase: "E."
Processing 00000000.tx.474: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.475: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.476: 19, 10512-10519[Abstract/Free FullText] Copyright  2001 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "19,"

Phrase: "10512-10519"

Phrase: "[Abstract/Free FullText"

Phrase: "] Copyright  2001 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

